HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Alert, oriented, tachypneic, frequent mildly weak cough.
   HEENT: Sclera anicteric, PERRL, EOMIs, MM slightly dry, oropharynx with
   large amount of dried and bright red blood over posterior pharynx and
   palate.  Nasopharynx without any evidence of blood.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning, but not clearly elevated.
   Lungs: Bilateral expiratory rhonchi and very coarse crackles.
   Tachypneic.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: CN II-XII intact.  Strength 5/5 in distal UEs and LEs.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Alert, oriented, tachypneic, frequent mildly weak cough.
   HEENT: Sclera anicteric, PERRL, EOMIs, MM slightly dry, oropharynx with
   large amount of dried and bright red blood over posterior pharynx and
   palate.  Nasopharynx without any evidence of blood.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning, but not clearly elevated.
   Lungs: Bilateral expiratory rhonchi and very coarse crackles.
   Tachypneic.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: CN II-XII intact.  Strength 5/5 in distal UEs and LEs.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the patient's condition and potential medical complications:

**Summary:**

The patient is a 76-year-old male with a history of coronary artery disease, mechanical aortic valve replacement, atrial fibrillation, and complete heart block. He was admitted for suspected methicillin-susceptible Staphylococcus aureus (MSSA) endocarditis, acute renal failure, and apparent acute interstitial nephritis (AIN). He developed respiratory failure, hemoptysis, and diffuse alveolar hemorrhage (DAH), and was transferred to the intensive care unit (ICU).

**Potential Medical Complications:**

1. **DAH:** The patient's hemoptysis and CXR findings suggest DAH, which is a life-threatening condition that requires prompt management.
2. **ARDS:** The patient's respiratory failure and hypoxemia may be due to ARDS, which is a complication of DAH.
3. **HAP:** The patient's hemoptysis and respiratory failure may be due to hospital-acquired pneumonia (HAP), which needs to be treated promptly.
4. **Anti-GBM disease:** The patient's vasculitic rash, elevated ESR, and microscopic hematuria suggest the possibility of anti-glomerular basement membrane (GBM) disease, which requires immediate attention.
5. **Renal failure:** The patient's acute renal failure is worsening, and further management is needed to prevent further deterioration.
6. **Cardiac complications:** The patient's atrial fibrillation, complete heart block, and mechanical aortic valve replacement increase his risk of cardiac complications, such as cardiac tamponade or cardiac arrest.
7. **Bleeding complications:** The patient's anticoagulation therapy and hemoptysis increase his risk of bleeding complications, such as gastrointestinal bleeding or intracranial hemorrhage.
8. **Infectious complications:** The patient's respiratory failure and hemoptysis may be due to an underlying infection, which needs to be treated promptly to prevent further complications.
9. **Renal biopsy:** The patient's microscopic hematuria and vasculitic rash suggest the possibility of renal biopsy, which may be necessary to determine the underlying cause of his renal failure.

**Plan:**

1. Intubate the patient to manage his respiratory failure and DAH.
2. Perform bronchoscopy to evaluate the patient's airway and obtain BAL samples.
3. Run recent medication exposures for possible culprits of DAH.
4. Initiate workup for and treatment of anti-GBM disease.
5. Consult rheumatology and pathology/pheresis to determine the underlying cause of the patient's vasculitic rash and renal failure.
6. Continue broad-spectrum antibiotics for HAP.
7. Hold heparin and anticoagulation therapy due to the patient's bleeding complications.
8. Monitor the patient's cardiac status closely to prevent cardiac complications.
9. Replete electrolytes and manage the patient's glycemic control to prevent further complications."
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed,
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg]
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic vasculitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic respiratory failure and hemoptysis.  Concerning for DAH
   given CXR findings as well.  Could also be pulmonary edema with
   hemorrhage due to anticoagulation, HAP with hemorrhage, development of
   ARDS with bleeding for other reasons or from other source.  DAH most
   concerning, particularly in light of prior ARF (?renal manifestations),
   vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative, ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   #. Endocarditis: Based on Duke Criteria (1 Major, 3 minor).  High grade
   MSSA bacteremia. Per ID, antibiotics for planned 8 week course.
   Switched from Nafcillin/Rifampin to Vancomycin [**1-17**] due to AIN.  Now on
   Cefazolin since [**1-22**] instead of Vanc as better for MSSA with increased
   dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial fibrillation/complete heart block. History this admission of
   CHB (as well as torsades, thought due to FQs), now s/p screw-in
   pacemaker.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permament pacer.
   #. Acute on Chronic Renal Failure: Cr 1.5 on presentation; trending up
   now 3.4. Thought to be AIN due to Nafcillin.  Now unclear if this is
   truly manifestation of systemic vasculitis or anti-GBM disease.  Has
   had microscopic hematuria in recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD.  s/p CABG and with DES x3 in one graft.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   # Leukoclastic vasculitis.  Thought due to Nafcillin or IE. Improving
   overall.  ?Could be related to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, s/p coronary artery bypass grafting, and mechanical aortic valve replacement, who was admitted with MSSA endocarditis, acute renal failure, and acute interstitial nephritis. He has developed respiratory failure, hypoxemia, and hemoptysis, and is being treated in the ICU. The patient's condition is complicated by atrial fibrillation, complete heart block, and torsades de pointes, and he has a history of leukocytoclastic vasculitis on skin biopsy.

Potential medical complications:

1. DAH (Diffuse Alveolar Hemorrhage): The patient's symptoms of hemoptysis and hypoxemia, along with the CXR findings, suggest the possibility of DAH. This is a life-threatening complication that requires prompt recognition and management.
2. ARF (Acute Renal Failure): The patient's creatinine levels have increased to 3.4, and he has a history of acute interstitial nephritis. This suggests that the patient may be at risk for further kidney damage.
3. Endocarditis: The patient has MSSA bacteremia, which is a potential complication of endocarditis. This requires continued antibiotic therapy and monitoring for signs of infection.
4. Atrial Fibrillation/Complete Heart Block: The patient's history of atrial fibrillation and complete heart block, along with his current symptoms, suggests the possibility of further cardiac complications.
5. Leukocytoclastic Vasculitis: The patient's history of leukocytoclastic vasculitis on skin biopsy, along with his current symptoms, suggests the possibility of further vasculitic complications.
6. HAP (Hospital-Acquired Pneumonia): The patient's symptoms of respiratory failure and hypoxemia suggest the possibility of HAP.
7. ARDS (Acute Respiratory Distress Syndrome): The patient's symptoms of respiratory failure and hypoxemia suggest the possibility of ARDS.
8. Pulmonary Edema: The patient's symptoms of respiratory failure and hypoxemia suggest the possibility of pulmonary edema.

Plan:

1. Intubate the patient to improve oxygenation and ventilation.
2. Continue antibiotic therapy for MSSA endocarditis and HAP.
3. Monitor the patient's renal function and adjust therapy as necessary.
4. Continue to manage the patient's cardiac arrhythmias and consider further cardiac interventions.
5. Monitor the patient's vasculitic symptoms and consider further vasculitic therapy.
6. Consider further diagnostic testing, such as bronchoscopy and echocardiography, to evaluate the patient's respiratory and cardiac status.
7. Continue to monitor the patient's respiratory and cardiac status and adjust therapy as necessary."
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, status post coronary artery bypass grafting (CABG) and mechanical aortic valve replacement (AVR), who was admitted to the hospital with symptoms of respiratory failure, hemorrhage, and renal failure. He was diagnosed with methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis with complications of acute kidney injury (AKI) and apparent acute interstitial nephritis (AIN), and leukocytoclastic dermatitis on skin biopsy. The patient was transferred to the intensive care unit (ICU) for management of his respiratory distress, hypoxemia, and hemoptysis, which is concerning for diffuse alveolar hemorrhage (DAH).

The patient's medical history is significant for atrial fibrillation (AF) with complete heart block (CHB), and he has been treated with anticoagulants, antiplatelet agents, and beta-blockers. He has also had a recent episode of torsades de pointes, which was thought to be related to the use of fluoroquinolones.

The patient's current medications include cefazolin, vancomycin, and heparin, which were started due to concerns about AIN and coagulopathy. He is also receiving steroids for his leukocytoclastic dermatitis and respiratory failure.

The patient's laboratory results show elevated levels of creatinine, blood urea nitrogen (BUN), and lactate dehydrogenase (LDH), which are consistent with AKI and AIN. His complete blood count (CBC) shows anemia, which is likely secondary to pulmonary hemorrhage. His electrocardiogram (ECG) shows AF with CHB, and his chest X-ray (CXR) shows bilateral lung infiltrates consistent with DAH.

The patient's clinical condition is unstable, and he requires close monitoring and management in the ICU. The patient's diagnosis is uncertain, and further testing is needed to determine the underlying cause of his symptoms. The patient's treatment plan includes management of his respiratory failure, AKI, and coagulopathy, as well as treatment of his endocarditis and leukocytoclastic dermatitis.

Potential medical complications:

1. Diffuse alveolar hemorrhage (DAH): The patient's symptoms of hemoptysis and bilateral lung infiltrates on CXR are concerning for DAH, which can be a life-threatening complication of endocarditis.
2. Acute kidney injury (AKI): The patient's elevated creatinine and BUN levels are consistent with AKI, which can be a complication of endocarditis, AIN, or other underlying medical conditions.
3. Coagulopathy: The patient's symptoms of bleeding and elevated INR are concerning for coagulopathy, which can be a complication of endocarditis, AIN, or other underlying medical conditions.
4. Leukocytoclastic dermatitis: The patient's symptoms of rash and skin biopsy results are consistent with leukocytoclastic dermatitis, which can be a complication of AIN or other underlying medical conditions.
5. Endocarditis: The patient's diagnosis of MSSA endocarditis is a serious condition that requires prompt treatment to prevent complications such as heart failure, stroke, and death.
6. Atrial fibrillation (AF): The patient's history of AF with CHB is a risk factor for stroke and other complications, and close monitoring is necessary to prevent these complications.
7. Pulmonary hypertension: The patient's symptoms of hypoxemia and respiratory failure are concerning for pulmonary hypertension, which can be a complication of endocarditis or other underlying medical conditions."
182149.0,283460,2128-01-28 07:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable. This case will likely need pathophysiological rather than
   ontological approach.
   # Hypoxemic Respiratory Failure
   Concerning for DAH given CXR findings as well.  Could also be pulmonary
   edema with hemorrhage due to anticoagulation, HAP with hemorrhage,
   development of ARDS with bleeding for other reasons or from other
   source.  DAH most concerning, particularly in light of prior ARF
   (?renal manifestations), vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative,
   ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   # Hemoptysis
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; trending up now 3.4. Thought to be AIN due to
   Nafcillin.  Now unclear if this is truly manifestation of systemic
   vasculitis or anti-GBM disease.  Has had microscopic hematuria in
   recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or IE. Improving overall.  ?Could be related
   to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Rash/Respiratory failure and hemorrhage/renal failure.
   24 Hour Events:
 PICC LINE - START [**2128-1-27**] 08:05 AM
 BLOOD CULTURED - At [**2128-1-27**] 09:30 AM
   two sets, one from each port of picc
 INVASIVE VENTILATION - START [**2128-1-27**] 10:40 AM
 EKG - At [**2128-1-27**] 12:15 PM
 ARTERIAL LINE - START [**2128-1-27**] 12:30 PM
 DIALYSIS CATHETER - START [**2128-1-27**] 01:05 PM
 BRONCHOSCOPY - At [**2128-1-27**] 01:25 PM
 TRANSTHORACIC ECHO - At [**2128-1-27**] 02:30 PM
   - HCT 27 -> 25.7 -> 24.4 (1U) -> 26 (1U) -> 27.5 -> 28
   - EKG: VPaced
   - Received Vit K IV
   - Renal: HD Line Placed, receiving CVVH now.
   - Rheum: 1. Would change steroids to solumedrol 1000 mg IV Daily for 3
   days 2. Stop allopurinol indefinitely. 3. Agree with transfusion
   medicine consult for possible plasmapheresis.  4. F/u with anti-GBM and
   ANCA. 5. Repeat echocardiogram (TEE) to evaluate for current cardiac
   status/function, vegetations and possible CHF. They would like to start
   Cytoxan if ID (given bacteremia) and Renal (i.e. If they agree with
   diagnosis) on board. Also recommend plasmaphoresis before Cytoxan.
   - Derm: Nothing
   - Intubated, Aline placed, Dialysis Catheter Placed.
   - Bronchoscopy: Diffuse Bleeding
   - ECHO:The left atrium is moderately dilated. Left ventricular wall
   thickness, cavity size and regional/global systolic function are normal
   (LVEF >55%). [Intrinsic left ventricular systolic function is likely
   more depressed given the severity of valvular regurgitation.] Right
   ventricular chamber size is normal. with borderline normal free wall
   function. There is abnormal septal motion/position consistent with
   right ventricular pressure/volume overload. A bileaflet aortic valve
   prosthesis is present. The transaortic gradient is normal for this
   prosthesis. No masses or vegetations are seen on the aortic valve, but
   cannot be fully excluded due to suboptimal image quality. Trace aortic
   regurgitation is seen. [The amount of regurgitation present is normal
   for this prosthetic aortic valve.] The mitral valve leaflets are
   moderately thickened. No masses or vegetations are seen on the mitral
   valve, but cannot be fully excluded due to suboptimal image quality. An
   eccentric, posteriorly directed jet of moderate (2+) mitral
   regurgitation is seen. No masses or vegetations are seen on the
   tricuspid valve, but cannot be fully excluded due to suboptimal image
   quality. Moderate [2+] tricuspid regurgitation is seen. There is
   moderate pulmonary artery systolic hypertension. There is no
   pericardial effusion. If clinically suggested, the absence of a
   vegetation by 2D echocardiography does not exclude endocarditis,
   especially on a bileaflet aortic valve. Compared with the prior study
   (images reviewed) of [**2128-1-8**], the severity of mitral and tricuspid
   regurgitation has increased. The right ventricular function may be
   slighlty less vigorous.
   - ID: Fine to change to Cefepime/Vancomycin. From Cefazolin.
   - Path: Nothing
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-27**] 09:40 AM
   Cefazolin - [**2128-1-27**] 10:00 AM
   Cefipime - [**2128-1-27**] 01:10 PM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 1 mEq./hour
   Midazolam (Versed) - 5 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-27**] 09:40 AM
   Midazolam (Versed) - [**2128-1-27**] 01:00 PM
   Fentanyl - [**2128-1-27**] 01:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-28**] 07:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 95/50(67) {78/42(56) - 140/70(94)} mmHg
   RR: 20 (18 - 30) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 88.1 kg (admission): 85 kg
   Height: 68 Inch
           Total In:
                                                                  3,243 mL
                                                                  2,401 mL
   PO:
           TF:
   IVF:
                                                                  2,298 mL
                                                                  2,051 mL
   Blood products:
                                                                    945 mL
                                                                    350 mL
   Total out:
                                                                  2,598 mL
                                                                  3,069 mL
   Urine:
                                                                  1,140 mL
                                                                    345 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    645 mL
                                                                   -668 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 550 (500 - 550) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 28 cmH2O
   Plateau: 21 cmH2O
   Compliance: 50 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/40/125/23/0 (6 a.m.)
   Ve: 3.9 L/min
   PaO2 / FiO2: 313
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   288 K/uL
   9.3 g/dL
   164 mg/dL
   2.1 mg/dL
   23 mEq/L
   4.7 mEq/L
   61 mg/dL
   101 mEq/L
   138 mEq/L
   28.0 %
   6.0 K/uL
        [image002.jpg] Free Ca 1.05.
                             [**2128-1-27**]  11:51 AM
                             [**2128-1-27**]  01:11 PM
                             [**2128-1-27**]  03:27 PM
                             [**2128-1-27**]  03:51 PM
                             [**2128-1-27**]  08:15 PM
                             [**2128-1-28**]  12:00 AM
                             [**2128-1-28**]  12:20 AM
                             [**2128-1-28**]  03:28 AM
                             [**2128-1-28**]  06:00 AM
                             [**2128-1-28**]  06:06 AM
   WBC
   13.4
   9.9
   6.0
   Hct
   25.7
   24.4
   26.0
   27.5
   28.0
   Plt
   [**Telephone/Fax (3) 11372**]88
   Cr
   3.1
   2.6
   2.1
   TCO2
   24
   23
   23
   25
   Glucose
   155
   193
   203
   164
   Other labs: PT / PTT / INR:17.6/28.7/1.6, Fibrinogen:373 mg/dL, Lactic
   Acid:0.8 mmol/L, Ca++:8.4 mg/dL, Mg++:2.3 mg/dL, PO4:4.3 mg/dL
   Fluid analysis / Other labs: BAL - no PMNs or bacteria seen on Gram
   stain.
   Imaging: Only line placement CXR today.
   Microbiology: No growth yet. C. difficile negative.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable. This case will likely need pathophysiological rather than
   ontological approach.
   # Hypoxemic Respiratory Failure
   Concerning for DAH given CXR findings as well.  Could also be pulmonary
   edema with hemorrhage due to anticoagulation, HAP with hemorrhage,
   development of ARDS with bleeding for other reasons or from other
   source.  DAH most concerning, particularly in light of prior ARF
   (?renal manifestations), vasculitic rash, elevated ESR.  [**Doctor First Name 1205**] negative,
   ANCA negative
   - Intubate now (larger tube preferred).
   - Bronchoscopy today; looking for progressive or continued blood with
   subsequent BALs.
   - Run recent medication exposures for possible culprits of DAH.
   - Initiate workup for and ?treatment for anti-GBM disease.  Send
   anti-GBM.  ?future renal biopsy.
   - Consult rheumatology and pathology/pheresis.
   - Will increase steroids to 125 mg Q6h, ?further increase if rec by
   rheum.
   - Will discuss cyclophosphamide with rheumatology.
   - ?pheresis today given concern for anti-GBM disease.  Will plan on
   line placement in anticipation of this and/or hemodialysis in near
   future.
   - Broad spectrum treatment for HAP and send sputum culture.  Will
   discuss with ID re: appropriate regimen (vanc plus beta lactam, ?still
   need to continue cefazolin).
   - Hold heparin, will not give protamine at this time.  WIll given
   vitamin K IV.
   # Hemoptysis
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; trending up now 3.4. Thought to be AIN due to
   Nafcillin.  Now unclear if this is truly manifestation of systemic
   vasculitis or anti-GBM disease.  Has had microscopic hematuria in
   recent past.
   - Resend urine.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - renally dose meds.
   - Change steroid to IV solumedrol.
   - diuresis likely when stabilized, vs. proceeding with HD.
   - ?future renal biopsy.
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or IE. Improving overall.  ?Could be related
   to systemic disease causing DAH.
   - will discuss with derm re: any relation to DAH.
   - steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Repeat blood cultures.
   - Will continue cefazolin for now, but given would like to treat for
   HAP, will discuss appropriate regimen.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia: Guaiac + stools this admission and have nuclear scan
   (negative).  Now with pulmonary hemorrhage likely.
   - recheck Hct Q8-Q12.
   - Consented for blood products.
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above.
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   #. Hypertension.
   - Holding antiHTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2B
   # Access: PICC
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, admitted to the hospital for MSSA endocarditis with complications of ARF, AIN, CHB, and torsades, and leukocytoclastic dermatitis on skin biopsy. He is currently intubated and receiving mechanical ventilation due to hypoxemic respiratory failure and hemoptysis. The patient has a complex medical history, including a recent diagnosis of acute on chronic renal failure, bacteremia, and atrial fibrillation with complete heart block.

Potential Medical Complications:

1. Respiratory Failure: The patient is at risk for further respiratory failure due to his underlying chronic respiratory disease, pneumonia, and mechanical ventilation.
2. Hemoptysis: The patient's hemoptysis may be a manifestation of coagulopathy, vasculitis, or a manifestation of his underlying endocarditis.
3. Acute on Chronic Renal Failure: The patient's creatinine levels are increasing, and he may require hemodialysis in the near future.
4. Leukoclastic Dermatitis: The patient's rash may be related to his underlying systemic disease, and further evaluation is needed to determine the cause.
5. Bacteremia: The patient has a high-grade MSSA bacteremia, and further treatment is needed to manage this infection.
6. Atrial Fibrillation/Complete Heart Block: The patient's atrial fibrillation and complete heart block may require further evaluation and treatment to manage these cardiac conditions.
7. Anemia: The patient's anemia may be related to his underlying chronic kidney disease, and further evaluation is needed to determine the cause.
8. CAD: The patient's CAD may be exacerbated by his underlying chronic kidney disease and endocarditis.

Recommendations:

1. Continue mechanical ventilation to manage the patient's respiratory failure.
2. Further evaluation is needed to determine the cause of the patient's hemoptysis and to manage this complication.
3. The patient's creatinine levels should be closely monitored, and hemodialysis may be necessary in the near future.
4. The patient's rash should be further evaluated to determine the cause and to manage this complication.
5. The patient's bacteremia should be treated with a full 8-week course of antibiotics, and further evaluation is needed to determine the cause of this infection.
6. The patient's atrial fibrillation and complete heart block should be further evaluated and treated to manage these cardiac conditions.
7. The patient's anemia should be further evaluated to determine the cause and to manage this complication.
8. The patient's CAD should be managed with medications and lifestyle modifications to reduce the risk of further cardiac complications.

ICU Care Plan:

1. Nutrition: The patient should receive total parenteral nutrition to manage his malnutrition and to support his recovery.
2. Glycemic Control: The patient's blood glucose levels should be closely monitored, and insulin therapy should be initiated as needed to manage hyperglycemia.
3. Lines: The patient's PICC line, arterial line, and dialysis catheter should be monitored closely to prevent complications.
4. Prophylaxis: The patient should receive stress ulcer prophylaxis and DVT prophylaxis to prevent complications.
5. Code Status: The patient's code status should be updated to full code.
6. Disposition: The patient should be transferred to a step-down unit or a telemetry unit once his respiratory failure is managed and his other medical conditions are stable."
182149.0,283460,2128-01-29 07:26:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications and potential medical complications are identified:

1. Endocarditis: The patient has been diagnosed with MSSA endocarditis, which is a serious infection of the heart valves.
2. Renal Failure: The patient has acute on chronic renal failure, which is a worsening of existing kidney damage. The patient's creatinine levels have increased from 1.5 to 3.4, and then decreased to 1.8 after CVVH.
3. Diffuse Alveolar Hemorrhage (DAH): The patient has a high likelihood of DAH, which is a life-threatening condition characterized by bleeding into the lungs.
4. Coagulopathy: The patient has a coagulopathy, which is a disorder of blood clotting. The patient's INR is 1.4, and the platelet count is normal, but may be dysfunctional due to ASA and uremia.
5. Leukoclastic Dermatitis: The patient has a rash on their skin, which is thought to be due to Nafcillin or allopurinol.
6. Bacteremia: The patient has a high-grade MSSA bacteremia, which is a serious infection that can spread to other parts of the body.
7. Atrial Fibrillation/Complete Heart Block: The patient has a history of atrial fibrillation and complete heart block, which is a serious cardiac condition.
8. Anemia: The patient has anemia, which is a decrease in the number of red blood cells. The patient's hemoglobin level is 9.0 g/dL.
9. CAD: The patient has a history of coronary artery disease (CAD) and has undergone coronary artery bypass grafting (CABG).
10. Vasculitis: The patient has a possibility of vasculitis, which is an inflammation of blood vessels. The patient's symptoms, including rash, hemoptysis, and renal failure, are consistent with vasculitis.

Potential medical complications that may arise include:

1. Sepsis: The patient's bacteremia and endocarditis increase the risk of developing sepsis, which is a life-threatening condition characterized by a systemic inflammatory response.
2. Cardiac complications: The patient's atrial fibrillation and complete heart block increase the risk of cardiac complications, such as arrhythmias and heart failure.
3. Respiratory failure: The patient's DAH and coagulopathy increase the risk of respiratory failure, which is a life-threatening condition characterized by inadequate breathing.
4. Renal failure: The patient's acute on chronic renal failure increases the risk of further kidney damage and failure.
5. Bleeding complications: The patient's coagulopathy and DAH increase the risk of bleeding complications, such as gastrointestinal bleeding and intracranial bleeding.
6. Infection: The patient's bacteremia and endocarditis increase the risk of developing further infections, such as pneumonia and septicemia.
7. Cardiovascular complications: The patient's CAD and history of CABG increase the risk of cardiovascular complications, such as myocardial infarction and cardiac arrhythmias.

The patient's treatment plan includes:

1. Antibiotics for endocarditis and bacteremia
2. CVVH for renal failure
3. Heparin for coagulopathy
4. Steroids for vasculitis and leukoclastic dermatitis
5. Plasmapheresis for vasculitis
6. Cytoxan therapy for vasculitis
7. Renal biopsy to rule out vasculitis
8. Cardiac monitoring for atrial fibrillation and complete heart block
9. Respiratory support for DAH
10. Nutritional support through tube feeds."
182149.0,283460,2128-01-29 07:26:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, Renal Failure, DAH
   24 Hour Events:
   - Some desynchrony with vent today, so fent and Versed increased
   - Bronch today some bronchial plugging with thrombus.
   - Rheumatology want us to continue discussing cytoxan and would like us
   to touch base with ID about starting this in the context of
   bacteremia/endocarditis. They would also like to ses phoresis prior to
   starting Cytoxan. They would like everyone to agree on the diagnosis of
   vasculitis before this proceeds.
   - Started tube feeds
   - Finished second unit of PRCs in a.m.
   - Spoke to both daughters yesterday with Renal - they agreed upon
   course of action (steroids and biopsy then decide about phoresis and
   Cytoxan)
   - Renal biopsy on a.m. of [**1-29**] - we will round on him early and would
   like to have DDAVP, platelets, coags drawn.
   - Final Renal recs: One dose DDAVP and FFP to start at 9:30. Biopsy
   will be around 11:00 and Changed cefepime 2g q12 for CVVH.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-28**] 10:00 AM
   Cefipime - [**2128-1-28**] 12:00 PM
   Infusions:
   Midazolam (Versed) - 7 mg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Fentanyl - 200 mcg/hour
   KCl (CRRT) - 2 mEq./hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-28**] 08:00 AM
   Midazolam (Versed) - [**2128-1-29**] 03:25 AM
   Fentanyl - [**2128-1-29**] 03:26 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-29**] 07:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.8
C (98.3
   Tcurrent: 35.9
C (96.7
   HR: 75 (75 - 75) bpm
   BP: 106/54(73) {73/30(46) - 123/59(82)} mmHg
   RR: 20 (12 - 29) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 84 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 16 (12 - 22)mmHg
   Total In:
                                                                  7,656 mL
                                                                  2,214 mL
   PO:
   TF:
                                                                     85 mL
                                                                    159 mL
   IVF:
                                                                  7,041 mL
                                                                  2,055 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                 10,809 mL
                                                                  2,842 mL
   Urine:
                                                                    664 mL
                                                                    148 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -3,153 mL
                                                                   -628 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 440 (440 - 550) mL
   Vt (Spontaneous): 406 (406 - 406) mL
   RR (Set): 20
   RR (Spontaneous): 0
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 31 cmH2O
   Plateau: 24 cmH2O
   Compliance: 44 cmH2O/mL
   SpO2: 97%
   ABG: 7.39/47/90.[**Numeric Identifier 128**]/25/2
   Ve: 10 L/min
   PaO2 / FiO2: 225
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   then later some desynchrony.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Labs / Radiology
   237 K/uL
   9.0 g/dL
   200 mg/dL
   1.8 mg/dL
   25 mEq/L
   4.5 mEq/L
   47 mg/dL
   99 mEq/L
   137 mEq/L
   26.7 %
   6.3 K/uL
        [image002.jpg]
                             [**2128-1-28**]  06:06 AM
                             [**2128-1-28**]  10:55 AM
                             [**2128-1-28**]  11:02 AM
                             [**2128-1-28**]  04:28 PM
                             [**2128-1-28**]  05:35 PM
                             [**2128-1-28**]  05:44 PM
                             [**2128-1-28**]  10:00 PM
                             [**2128-1-28**]  10:24 PM
                             [**2128-1-29**]  03:57 AM
                             [**2128-1-29**]  04:00 AM
   WBC
   4.4
   5.9
   6.3
   Hct
   26.3
   27.2
   27.2
   26.7
   Plt
   249
   250
   237
   Cr
   1.9
   1.9
   1.8
   TCO2
   25
   28
   28
   29
   29
   30
   Glucose
   [**Telephone/Fax (3) 11377**]93
   200
   Other labs: PT / PTT / INR:15.7/26.4/1.4, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.0 mg/dL, Mg++:2.1 mg/dL, PO4:3.5 mg/dL
   Imaging: Chest Xray ([**1-27**]): Pending
   Microbiology: Sputum:
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         SPARSE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   BAL:
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Preliminary):    NO GROWTH, <1000 CFU/ml.
   Blood ([**1-27**]): Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Repeat bronchoscopy today to remove thrombus plugging and examine
   again.
   - Await anti-GBM
   - Discuss renal biopsy
   - Continue to appreciate input of Rheumatology and Renal
   - Continue Solu-medrol
   - Consider Cytoxan and plasmapheresis with d/w Renal and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
 stop
   cefazolin
   - Hold heparin, ASA
   # Hemoptysis and Coagulopathy
   Evidence, perhaps with purpuric rash, of coagulopathy, or potentially
   as a manifestation of vasculitis. For the former and possibly uremic
   platelets, anticoagulant therapy. In favor of the latter is unifying
   diagnosis and co-occurrence with renal disease and rash. See discussion
   above
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 2.1 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.  Now on Cefazolin since [**1-22**]
   instead of Vanc as better for MSSA with increased dosing [**1-25**].
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8-Q12.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition: Tube Feeds
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:  H2R Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease (CAD), mechanical aortic valve replacement (AVR), and atrial fibrillation (AFib) who was admitted for methicillin-susceptible Staphylococcus aureus (MSSA) endocarditis with complications of acute renal failure (ARF), acute interstitial nephritis (AIN), and diffuse alveolar hemorrhage (DAH). The patient is currently intubated and receiving mechanical ventilation, and has a history of cardiac tamponade, torsades de pointes, and leukocytoclastic dermatitis.

Potential Medical Complications:

1. Vasculitis: The patient's symptoms, including fever, rash, and renal failure, are consistent with vasculitis. The presence of anti-GBM antibodies and the patient's response to treatment with corticosteroids and plasmapheresis support this diagnosis.
2. Coagulopathy: The patient's bleeding diathesis, including hemoptysis and gastrointestinal bleeding, is consistent with a coagulopathy. The presence of anti-GBM antibodies and the patient's response to treatment with corticosteroids and plasmapheresis support this diagnosis.
3. Acute Kidney Injury (AKI): The patient's AKI is likely due to a combination of factors, including sepsis, nephrotoxic medications, and underlying kidney disease.
4. Respiratory Failure: The patient's respiratory failure is likely due to a combination of factors, including pneumonia, acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD).
5. Cardiac Complications: The patient's cardiac tamponade and torsades de pointes are likely due to the patient's underlying cardiac disease and the use of certain medications.
6. Gastrointestinal Bleeding: The patient's gastrointestinal bleeding is likely due to a combination of factors, including coagulopathy, vasculitis, and underlying gastrointestinal disease.

Plan:

1. Continue to monitor the patient's symptoms and laboratory results to assess the severity of the vasculitis and coagulopathy.
2. Continue to treat the patient with corticosteroids and plasmapheresis to manage the vasculitis and coagulopathy.
3. Continue to monitor the patient's renal function and adjust treatment as necessary to manage the AKI.
4. Continue to manage the patient's respiratory failure with mechanical ventilation and other supportive measures.
5. Continue to monitor the patient's cardiac function and adjust treatment as necessary to manage the cardiac complications.
6. Continue to monitor the patient's gastrointestinal bleeding and adjust treatment as necessary to manage the bleeding.
7. Consider performing a renal biopsy to assess the severity of the vasculitis and to guide treatment.
8. Consider performing a bronchoscopy to assess the severity of the pneumonia and to guide treatment.
9. Consider performing a TEE to assess the severity of the endocarditis and to guide treatment.

Order:

1. Continue to administer corticosteroids and plasmapheresis to manage the vasculitis and coagulopathy.
2. Continue to monitor the patient's renal function and adjust treatment as necessary to manage the AKI.
3. Continue to manage the patient's respiratory failure with mechanical ventilation and other supportive measures.
4. Continue to monitor the patient's cardiac function and adjust treatment as necessary to manage the cardiac complications.
5. Continue to monitor the patient's gastrointestinal bleeding and adjust treatment as necessary to manage the bleeding.
6. Perform a renal biopsy to assess the severity of the vasculitis and to guide treatment.
7. Perform a bronchoscopy to assess the severity of the pneumonia and to guide treatment.
8. Perform a TEE to assess the severity of the endocarditis and to guide treatment."
182149.0,283460,2128-01-30 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   .
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   .
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's daily progress note, here is a summary of the patient's condition and potential medical complications:

**Patient Summary:**

The patient is a 76-year-old male with a history of CAD, s/p CABG, and mechanical AVR, currently hospitalized for MSSA endocarditis with complications of ARF, AIN, CHB, and leukocytoclastic dermatitis. The patient is intubated and on mechanical ventilation due to respiratory distress and hypoxemia.

**Potential Medical Complications:**

1. **Hypoxemic Respiratory Failure:** The patient's respiratory status is a concern, and further evaluation is needed to determine the underlying cause of the hypoxemia. The patient's pulmonary edema and anticoagulation may be contributing factors.
2. **Acute on Chronic Renal Failure:** The patient's creatinine levels are elevated, and further evaluation is needed to determine the underlying cause of the acute kidney injury. AIN due to Nafcillin or allopurinol is a possibility.
3. **Leukoclastic Dermatitis:** The patient's rash is improving, but further evaluation is needed to determine the underlying cause.
4. **Bacteremia:** The patient has high-grade MSSA bacteremia, and antibiotics are being continued for a full 8-week course.
5. **Atrial Fibrillation/Complete Heart Block:** The patient's cardiac rhythm is abnormal, and further evaluation is needed to determine the underlying cause.
6. **Anemia:** The patient's anemia is worsening, and further evaluation is needed to determine the underlying cause.
7. **CAD:** The patient's CAD is a concern, and further evaluation is needed to determine the underlying cause of the patient's symptoms.
8. **s/p AVR:** The patient's AVR is a concern, and further evaluation is needed to determine the underlying cause of the patient's symptoms.
9. **Hypertension:** The patient's hypertension is a concern, and further evaluation is needed to determine the underlying cause.

**Assessment and Plan:**

The patient's condition is complex, and further evaluation is needed to determine the underlying causes of the patient's symptoms. The patient is currently receiving antibiotics, anticoagulation, and other supportive therapies. The patient's family has been informed of the patient's condition, and code status has been discussed. The patient's disposition is ICU pending clinical improvement."
182149.0,283460,2128-01-30 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Endocarditis, [**Last Name (un) **], DAH
   24 Hour Events:
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: stable
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefazolin - [**2128-1-27**] 10:00 AM
   Vancomycin - [**2128-1-29**] 01:33 PM
   Cefipime - [**2128-1-30**] 12:03 AM
   Infusions:
   Fentanyl - 125 mcg/hour
   Midazolam (Versed) - 3 mg/hour
   KCl (CRRT) - 2 mEq./hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-29**] 08:25 AM
   Fentanyl - [**2128-1-29**] 11:28 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-30**] 07:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.2
C (97.2
   HR: 75 (75 - 76) bpm
   BP: 134/62(88) {100/50(69) - 146/70(95)} mmHg
   RR: 15 (9 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 78.6 kg (admission): 85 kg
   Height: 68 Inch
             Total In:
                                                                  7,709 mL
                                                                  2,170 mL
   PO:
             TF:
                                                                    497 mL
                                                                    228 mL
   IVF:
                                                                  6,409 mL
                                                                  1,942 mL
   Blood products:
                                                                    573 mL
   Total out:
                                                                  9,633 mL
                                                                  3,659 mL
   Urine:
                                                                    473 mL
                                                                    170 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,924 mL
                                                                 -1,489 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 440 (440 - 440) mL
   Vt (Spontaneous): 781 (711 - 781) mL
   PS : 10 cmH2O
   RR (Set): 20
   RR (Spontaneous): 10
   PEEP: 12 cmH2O
   FiO2: 40%
   RSBI Deferred: PEEP > 10
   PIP: 23 cmH2O
   Plateau: 21 cmH2O
   Compliance: 62.9 cmH2O/mL
   SpO2: 99%
   ABG: 7.43/44/160/26/4
   Ve: 8.2 L/min
   PaO2 / FiO2: 400
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   248 K/uL
   9.2 g/dL
   271 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.2 mEq/L
   44 mg/dL
   99 mEq/L
   138 mEq/L
   28.2 %
   8.5 K/uL
        [image002.jpg]
                             [**2128-1-29**]  12:33 PM
                             [**2128-1-29**]  12:34 PM
                             [**2128-1-29**]  12:46 PM
                             [**2128-1-29**]  04:42 PM
                             [**2128-1-29**]  06:19 PM
                             [**2128-1-29**]  06:29 PM
                             [**2128-1-30**]  12:14 AM
                             [**2128-1-30**]  12:24 AM
                             [**2128-1-30**]  04:20 AM
                             [**2128-1-30**]  04:28 AM
   WBC
   8.5
   Hct
   27.4
   27.9
   28.7
   28.2
   Plt
   263
   248
   Cr
   1.8
   1.7
   1.6
   TCO2
   31
   32
   30
   30
   Glucose
   175
   252
   272
   271
   Other labs: PT / PTT / INR:15.2/26.0/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.9 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Imaging: CXR: Pending
   Microbiology: [**2128-1-27**] 2:16 am SPUTUM      Source: Expectorated.
      GRAM STAIN (Final [**2128-1-27**]):
         [**11-8**] PMNs and <10 epithelial cells/100X field.
         1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      RESPIRATORY CULTURE (Preliminary):
         MODERATE GROWTH OROPHARYNGEAL FLORA.
         GRAM NEGATIVE ROD(S).    MODERATE GROWTH.
   [**2128-1-27**] 1:34 pm BRONCHOALVEOLAR LAVAGE
                               **FINAL REPORT [**2128-1-29**]**
      GRAM STAIN (Final [**2128-1-27**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      RESPIRATORY CULTURE (Final [**2128-1-29**]):    NO GROWTH, <1000 CFU/ml.
   Blood Cultures: [**1-27**] Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   Concern for immune mediated unifying diagnosis, versus coagulopathy and
   AIN with leukoclastic dermatitis. One critical piece of information may
   be whether immune cells cluster at arterioles in skin (vasculitis) or
   around capillaries (AIN and leukoclastic dermatitis proper). This will
   have important implications for treatment. Anti-GBM antibody test will
   be back tomorrow night at earliest per lab/pathologist. Rheumatology
   feel that this likely represents vasculitis and would like to broaden
   treatment to include plasmaphoresis then Cytoxan therapy. This will
   likely depend on whether pathology and Renal also feel that this is a
   vasculitis, not just AIN with associated rash after nafcillin or
   allopurinol. Goodpasture
s unlikely in view of presentation. ANCA is
   negative, but this is the case in about 20% of Wegener
s cases. No
   dysmorphic reds in urine, but this can sometimes be the case. Possible
   other vasculidites, but IgG, IgM and IgA staining in skin were not
   remarkable.
   # Hypoxemic Respiratory Failure and Possible Vasculitis
   Given findings on CXR, CVP, clinical presentation and bronchoscopy,
   likely secondary to diffuse alveolar hemorrhage and fluid overload. ESR
   is elevated, there is a pupruic macular rash and renal failure, all
   concerning for vasculitis, although there are other possibilities. [**Doctor First Name 1205**]
   and ANCA are negative and anti-GBM is pending. If we seek a unifying
   diagnosis, may be that anti-GBM is negative given skin process.
   Variability in antibody responsible may account for this, and general
   approaches and pathology may eventually be most helpful. Renal biopsy
   is possible (see below). Presently conditions of each organ stabilized
   on high dose steroids, also suggestive. Rheumatology raised Cytoxan
   treatment and plasmaphoresis, but we will need to discuss this further
   with Renal and Pathology.
   - Renal Biopsy this AM
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Await anti-GBM
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Continue Solu-medrol
   - sp Renal Biopsy, consider Cytoxan and plasmapheresis with d/w Renal
   and Rheumatology
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Hold heparin, ASA
   - Continue to remove fluid with CVVH
   # Coagulopathy: Plan for Kidney Biopsy today. INR 1.4 this AM,
   Platelets NL however may be dysfunctional given ASA /Uremia.
   - DDAVP today
   - FFP during procedure
   - One unit platlets.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.8 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Now unclear if this is truly manifestation of systemic
   vasculitis or drug reaction. White cells and eosinophils in urine
   consistent with either, although more classic of AIN.
   - f/u renal recs, discuss thoughts re: renal manifestation as above.
   - Renally dose/CVVH dose meds.
   - Management as above, including IV Solu-medrol.
   - Possible renal biopsy tomorrow given that we are now holding
   anticoagulants
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Hold heparin as above, will restart anticoagulation sp biopsy with
   very low ptt goal.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now, knowing high risk with DES.  Minimize time off ASA.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - No heparin for now
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - As above, holding heparin.
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-30**] 04:26 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: H2Blocker
   VAP:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for now.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 76-year-old male with a history of coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation. He is currently hospitalized with a diagnosis of MSSA endocarditis, acute kidney injury, and leukocytoclastic dermatitis. The patient is experiencing respiratory distress, hypoxemia, and hemoptysis, which is concerning for diffuse alveolar hemorrhage.

The patient's laboratory results show elevated white blood cell count, elevated lactate dehydrogenase, and elevated creatinine. The patient's coagulation profile shows an international normalized ratio (INR) of 1.4, which is elevated. The patient's platelet count is normal, but may be dysfunctional given the use of aspirin and uremia.

The patient's physical examination reveals a supple neck, bilateral expiratory rhonchi and coarse crackles, and a diffuse rash over the trunk and extremities. The patient's skin biopsy shows leukocytoclastic dermatitis.

The patient's respiratory support includes mechanical ventilation with a tidal volume of 440 mL and a positive end-expiratory pressure (PEEP) of 12 cmH2O. The patient's oxygen saturation is 99%.

The patient's treatment plan includes broad-spectrum antibiotics for hospital-acquired pneumonia, anticoagulation with heparin, and plasmapheresis. The patient is also receiving steroids for vasculitis and leukocytoclastic dermatitis.

Potential medical complications that may arise include:

1. Diffuse alveolar hemorrhage: The patient's respiratory distress and hypoxemia may worsen, leading to further respiratory failure.
2. Coagulopathy: The patient's INR is elevated, which may increase the risk of bleeding.
3. Acute kidney injury: The patient's creatinine level is elevated, which may worsen kidney function.
4. Vasculitis: The patient's skin biopsy shows leukocytoclastic dermatitis, which may indicate vasculitis.
5. Endocarditis: The patient's MSSA endocarditis may progress, leading to further complications.
6. Respiratory failure: The patient's mechanical ventilation may not be effective in managing his respiratory distress.
7. Sepsis: The patient's bacteremia and leukocytoclastic dermatitis may indicate sepsis.
8. Thrombosis: The patient's coagulopathy and use of anticoagulation may increase the risk of thrombosis.

It is essential to closely monitor the patient's condition and adjust his treatment plan accordingly to prevent or manage these potential complications."
182149.0,283460,2128-01-31 07:30:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation, who was admitted for methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis with complications of acute kidney injury, anemia, and leukocytoclastic dermatitis. He was transferred to the medical intensive care unit (MICU) due to respiratory distress, hypoxemia, and hemoptysis, concerning for diffuse alveolar hemorrhage (DAH). The patient has a history of cardiac surgery and is currently receiving anticoagulation therapy.

Potential Medical Complications:

1. Diffuse Alveolar Hemorrhage (DAH): The patient's respiratory distress, hypoxemia, and hemoptysis suggest DAH, which is a life-threatening complication of endocarditis. The patient is at risk for further bleeding and respiratory failure.
2. Acute Kidney Injury (AKI): The patient's elevated creatinine levels and decreased urine output indicate AKI, which is a common complication of endocarditis. The patient is at risk for further kidney damage and may require dialysis.
3. Anemia: The patient's anemia is likely due to bleeding and may be exacerbated by the patient's underlying cardiac condition. The patient is at risk for further bleeding and may require blood transfusions.
4. Leukocytoclastic Dermatitis: The patient's skin lesions are likely due to an allergic reaction to the antibiotics or other medications. The patient is at risk for further skin lesions and may require additional treatment.
5. Bacteremia: The patient has a high-grade MSSA bacteremia, which is a serious complication of endocarditis. The patient is at risk for further sepsis and may require additional antibiotics.
6. Atrial Fibrillation/Complete Heart Block: The patient's atrial fibrillation and complete heart block are likely due to the patient's underlying cardiac condition and may be exacerbated by the patient's endocarditis. The patient is at risk for further cardiac complications and may require additional treatment.
7. Hypertension: The patient's hypertension is likely due to the patient's underlying cardiac condition and may be exacerbated by the patient's endocarditis. The patient is at risk for further cardiac complications and may require additional treatment.
8. Coagulopathy: The patient's coagulopathy is likely due to the patient's endocarditis and may be exacerbated by the patient's anticoagulation therapy. The patient is at risk for further bleeding and may require additional treatment.

Recommendations:

1. Continue to monitor the patient's respiratory status and provide supportive care as needed.
2. Continue to manage the patient's AKI with dialysis and medications as needed.
3. Monitor the patient's anemia and provide blood transfusions as needed.
4. Continue to treat the patient's leukocytoclastic dermatitis with topical corticosteroids and antibiotics as needed.
5. Continue to manage the patient's bacteremia with antibiotics and monitor for further sepsis.
6. Monitor the patient's atrial fibrillation and complete heart block and provide additional treatment as needed.
7. Monitor the patient's hypertension and provide additional treatment as needed.
8. Continue to manage the patient's coagulopathy with anticoagulation therapy and monitor for further bleeding."
182149.0,283460,2128-01-31 07:30:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 76M with CAD s/p CABG, s/p mechanical AVR, Afib;
   currently hospitalized for MSSA endocarditis with complications of ARF
   and apparent AIN, CHB and torsades, and leukocytoclastic dermatitis on
   skin biopsy, now transferred to MICU with respiratory distress,
   hypoxemia, and hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Called lab processing anti GBM and verbally reported to be negative.
   - Serial hematocrit s/p procedure: 27.4 -> 27.9 -> xx
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis.
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids?
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy.
   - CVVH to remove 250cc hour, up to 400cc hour later.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, sedated, unresponsive, synchronus with AC this a.m.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: no foley
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Heavily sedated.
   Skin: Petechial rash lower extremity.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure:
   At this time thought to be secondary to pulmonary edema and
   anticoagulation given negative anti-GBM and rather unrevealing renal
   biopsy. ESR is elevated, there is a pupruic macular rash and renal
   failure, all concerning for vasculitis, although there are other
   possibilities. [**Doctor First Name 1205**] and ANCA are negative. Patient clinically improving
   sp diuresis and steroids. HCT stable.
   - FU Renal Biopsy
   - Maintain intubation for now given lesser chance of hemorrhage without
   cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology ,Renal , Derm
   - Broad spectrum treatment for HAP
 cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70,
   - Hold ASA until tomorrow
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time.
   #. Acute on Chronic Renal Failure
   Cr 1.5 on presentation; up to 3.4, now 1.6 s/p CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below).  Renal biopsy without changes consistent with AIN, may be
   secondary to immune complex deposition in the setting of endocarditis.
   Awaiting immunostaining currently.
   - f/u renal recs, discuss thoughts
   - Renally dose/CVVH dose meds.
   - Lower Dose steroids at this time, however will follow up with renal
   regarding further treatment.
   - FU biopsy results
   # Leukoclastic Dermatitis
   Thought due to Nafcillin or allopurinol. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - restart heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Now with pulmonary hemorrhage likely. If diffuse vasculitis or actually
   secondary to primary coagulopathy then need to maintain suspicion for
   other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for until tomorrow, knowing high risk with DES.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease (CAD) and mechanical aortic valve replacement (AVR), who is currently hospitalized for methicillin-sensitive Staphylococcus aureus (MSSA) endocarditis with complications of acute renal failure (ARF), apparent acute interstitial nephritis (AIN), and leukocytoclastic dermatitis. He has been transferred to the medical intensive care unit (MICU) due to respiratory distress, hypoxemia, and hemoptysis, concerning for diffuse alveolar hemorrhage (DAH).

The patient's current condition is as follows:

* Respiratory: intubated and mechanically ventilated with CPAP/PSV mode, with a respiratory rate of 15 breaths per minute and a PEEP of 5 cmH2O.
* Cardiovascular: ventricularly paced with a heart rate of 75 beats per minute, blood pressure of 128/57 mmHg, and a central venous pressure (CVP) of 15 mmHg.
* Renal: acute renal failure with a creatinine level of 1.6 mg/dL, requiring continuous renal replacement therapy (CRRT).
* Hematological: anemia with a hemoglobin level of 9.6 g/dL, leukocytosis with a white blood cell count of 13.1 K/uL, and thrombocytopenia with a platelet count of 292 K/uL.
* Dermatological: diffuse rash over the trunk and extremities, consistent with leukocytoclastic dermatitis.

Potential Medical Complications:

1. Diffuse Alveolar Hemorrhage (DAH): The patient's respiratory distress, hypoxemia, and hemoptysis are concerning for DAH, which could worsen his respiratory status and lead to respiratory failure.
2. Acute Kidney Injury (AKI): The patient's ARF could progress to AKI, requiring further renal replacement therapy and increasing his risk of complications such as sepsis and multi-organ failure.
3. Sepsis: The patient's bacteremia and endocarditis increase his risk of developing sepsis, which could lead to multi-organ failure and death.
4. Atrial Fibrillation (AFib): The patient's history of AFib and complete heart block (CHB) increase his risk of developing further cardiac arrhythmias, which could worsen his cardiovascular status.
5. Gastrointestinal Bleeding: The patient's anemia and thrombocytopenia increase his risk of developing gastrointestinal bleeding, which could worsen his hemodynamic status.
6. Infection: The patient's endocarditis and bacteremia increase his risk of developing further infections, which could worsen his overall condition.
7. Cardiovascular Complications: The patient's history of CAD and AVR increase his risk of developing cardiovascular complications such as myocardial infarction, cardiac tamponade, and heart failure.

Assessment and Plan:

The patient's current condition and potential medical complications require close monitoring and management. The plan is to continue to manage his respiratory, cardiovascular, and renal status, as well as to address his anemia and thrombocytopenia. The patient will require ongoing surveillance for signs of DAH, AKI, sepsis, AFib, gastrointestinal bleeding, infection, and cardiovascular complications. Further consultations with rheumatology, renal, and dermatology services are recommended to optimize the patient's care."
182149.0,283460,2128-01-31 07:30:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Presented with bacteremia. Tranferred to ICU with
   respiratory failure and hemoptysis.
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis (but awaiting final results).
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids (for AIN in this
   case)
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy (for leukocytoclastic cutaneous vasculitis)
   - CVVH to remove 250cc hour, up to 400cc hour later, then back to 200
   cc this a.m.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria with about 300
   mL output of light red wine shaded respiratory secretions from midnight
   until 10 a.m.
   - Still await final pathology results
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   LOS fluid balance
 10 L
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given copious secretions
   this a.m. If production decreases then will consider extubation because
   there is no other reason to maintain vent. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving sp diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - FU Renal Biopsy
   - Maintain intubation for now given secretions and lesser chance of
   hemorrhage without cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Broad spectrum treatment for HAP, MSSA bacteremia in context of AVR
   cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70
   - Hold ASA for now.
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time, 40 mg today and 30 mg
   tomorrow for course of treatment for AIN (check with Renal but in order
   of four weeks)
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although allopurinal and warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - f/u renal recs
   - Steroids to treat AIN, 30 mg daily for course to be determined by
   Renal
 in order of weeks
   - Renally dose/CVVH dose meds.
   - Continue CVVH
   - FU biopsy results
   - Continue to follow urine output
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Follow urine output and bloodiness
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or allopurinol
 case
   reports of warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now given increased bloody secretions overnight.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Presented with bacteremia. Tranferred to ICU with
   respiratory failure and hemoptysis.
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   24 Hour Events:
   [**1-29**]
   - Patient s/p renal biopsy; results do not show RPGN or significant
   inflammation consistent with vasculitis (but awaiting final results).
   [**1-30**]
   - Changed to methyprednisone 40mg IV Q12
   - Heparin gtt restarted @ 1000, goal ptt 50-70. Met goal citrate
   stopped.
   - Rheum: Continue Steroids taper.
   - Renal: Restart Heparin, No Ultrasound, Steroids (for AIN in this
   case)
   - Tube Feeds at goal
   - Derm: Do not typically treat with steroids unless systemic, so would
   not need systemic therapy (for leukocytoclastic cutaneous vasculitis)
   - CVVH to remove 250cc hour, up to 400cc hour later, then back to 200
   cc this a.m.
   - HCT: 28.5 ->29.4 ->30.6
   - Continued bloody secretions with suctioning, hematuria with about 300
   mL output of light red wine shaded respiratory secretions from midnight
   until 10 a.m.
   - Still await final pathology results
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-30**] 10:00 AM
   Cefipime - [**2128-1-30**] 11:16 PM
   Infusions:
   Heparin Sodium - 1,150 units/hour
   Fentanyl - 115 mcg/hour
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 2 mEq./hour
   Midazolam (Versed) - 2 mg/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-30**] 09:30 AM
   Midazolam (Versed) - [**2128-1-30**] 12:40 PM
   Fentanyl - [**2128-1-30**] 12:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-1-31**] 07:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.3
C (97.4
   Tcurrent: 36.3
C (97.4
   HR: 75 (75 - 87) bpm
   BP: 128/57(83) {100/48(67) - 180/76(113)} mmHg
   RR: 14 (10 - 22) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 15 (6 - 20)mmHg
   Total In:
                                                                  7,933 mL
                                                                  2,810 mL
   PO:
   TF:
                                                                    722 mL
                                                                    223 mL
   IVF:
                                                                  7,151 mL
                                                                  2,407 mL
   Blood products:
   Total out:
                                                                 12,684 mL
                                                                  3,244 mL
   Urine:
                                                                    613 mL
                                                                    176 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,751 mL
                                                                   -434 mL
   LOS fluid balance
 10 L
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 654 (440 - 704) mL
   PS : 5 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 35
   PIP: 17 cmH2O
   SpO2: 97%
   ABG: 7.45/39/111/28/3
   Ve: 9 L/min
   PaO2 / FiO2: 277
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   292 K/uL
   9.6 g/dL
   203 mg/dL
   1.2 mg/dL
   28 mEq/L
   4.1 mEq/L
   39 mg/dL
   100 mEq/L
   139 mEq/L
   30.0 %
   13.1 K/uL
        [image002.jpg]
                             [**2128-1-30**]  10:24 AM
                             [**2128-1-30**]  10:34 AM
                             [**2128-1-30**]  04:17 PM
                             [**2128-1-30**]  04:21 PM
                             [**2128-1-30**]  04:35 PM
                             [**2128-1-30**]  10:17 PM
                             [**2128-1-30**]  10:28 PM
                             [**2128-1-31**]  04:15 AM
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
   WBC
   13.1
   Hct
   28.5
   29.4
   30.6
   30.0
   Plt
   292
   Cr
   1.6
   1.4
   1.2
   TCO2
   30
   29
   29
   32
   28
   Glucose
   [**Telephone/Fax (3) 11389**]03
   Other labs: PT / PTT / INR:14.7/53.3/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:8.7 mg/dL, Mg++:1.9 mg/dL, PO4:1.6 mg/dL
   Imaging: Asymmetric, severe pulmonary hemorrhage, both lungs,
   previously improved,stable since [**2128-1-29**].
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given copious secretions
   this a.m. If production decreases then will consider extubation because
   there is no other reason to maintain vent. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving sp diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - FU Renal Biopsy
   - Maintain intubation for now given secretions and lesser chance of
   hemorrhage without cough and management of respiratory parameters.
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Broad spectrum treatment for HAP, MSSA bacteremia in context of AVR
   cefepime and vancomycin
   - Restart Heparin this AM, no bolus. PTT goal 50-70
   - Hold ASA for now.
   - Continue to remove fluid with CVVH
   - Continue lower dose steroids at this time, 40 mg today and 30 mg
   tomorrow for course of treatment for AIN (check with Renal but in order
   of four weeks)
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although allopurinal and warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - f/u renal recs
   - Steroids to treat AIN, 30 mg daily for course to be determined by
   Renal
 in order of weeks
   - Renally dose/CVVH dose meds.
   - Continue CVVH
   - FU biopsy results
   - Continue to follow urine output
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Follow urine output and bloodiness
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or allopurinol
 case
   reports of warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Steroids as above.
   - FU Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommend
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures.
   - Based on ID input will cover this and possible HAP with vancomycin
   and cefepime.
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue heparin as above.
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GIT
   - Recheck Hct Q8.
   - Guaiac stool
   - Consented for blood products
   - Maintain access and active type and screen
   - H2 blocker given some concern that PPI could be causing AIN.
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin.
   - Hold ASA for now given increased bloody secretions overnight.
   - Holding ACE in the setting of renal failure.
   - Holding BB for now.
   - Heparin as above.
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker.
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Nutren 2.0 (Full) - [**2128-1-31**] 04:19 AM 30 mL/hour
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 76-year-old male with a complex medical history, including CAD, s/p CABG, and s/p mechanical AVR, who was admitted for MSSA endocarditis with complications of ARF, apparent AIN, CHB, and torsades, and leukocytoclastic dermatitis on skin biopsy. He was transferred to the MICU with respiratory distress, hypoxemia, and hemoptysis, concerning for DAH.

The patient's current condition is as follows:

* Respiratory status: Hypoxemic respiratory failure, requiring intubation and ventilation. The etiology of the hemorrhage is unclear, and differential diagnoses include vasculitic and autoimmune processes, coagulopathy, or the effect of pulmonary edema in the context of coagulopathy.
* Renal status: Acute on chronic renal failure, with a creatinine level of 1.2 mg/dL, and evidence of AIN, including white cell casts, worsened renal function, and urinary eosinophils.
* Hematuria: Likely secondary to biopsy in the context of coagulopathy, and the patient is at risk for continued bleeding.
* Leukoclastic dermatitis: Improving, but thought to be related to Nafcillin or allopurinol.
* Bacteremia: High-grade MSSA bacteremia, fulfilling Duke Criteria for endocarditis.
* Atrial fibrillation/complete heart block: The patient has a history of CHB and torsades, and is currently ventricularly pacing.
* Anemia: Hematocrit has been stable, but is now affected by pulmonary hemorrhage.

Potential medical complications that can arise from this patient's condition include:

* Worsening respiratory failure, potentially leading to ARDS or death
* Continued bleeding, potentially leading to hypovolemic shock or death
* Kidney damage or failure, potentially leading to end-stage renal disease
* Increased risk of infection, potentially leading to sepsis or death
* Cardiovascular complications, potentially leading to myocardial infarction or cardiac arrest
* Neurological complications, potentially leading to stroke or seizures

To address these potential complications, the patient should receive:

* Close monitoring of his respiratory status, including frequent ABG and oxygen saturation measurements
* Aggressive management of his bleeding, including CVVH and transfusions as needed
* Continued treatment for his AIN, including steroids and renal biopsy results
* Antibiotic therapy for his MSSA bacteremia and potential HAP
* Cardiovascular monitoring, including echocardiography and cardiac enzymes
* Neurological monitoring, including frequent assessments of his mental status and neurological function
* Close monitoring of his anemia, including frequent Hct measurements and transfusions as needed

The patient's family should be educated on his condition and potential complications, and should be involved in his care and decision-making process. The patient's code status should be reviewed and updated as necessary."
182149.0,283460,2128-02-01 07:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given bloody secretions; can likely restart today
   - Continue to remove fluid with CVVH
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Continue to remove fluid with CVVH
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions; can likely restart today
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions, pressure support of [**5-19**]. Draining thin secretions from
   lung that are moderately blood, like light red wine.
   Neck: supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles.
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with hematuria color of red wine.
   Ext: warm, well perfused, 2+ pitting LE edema.  Diffuse rash over trunk
   and extremities - macular nonblanching purpuric rash.
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given bloody secretions; can likely restart today
   - Continue to remove fluid with CVVH
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Continue to remove fluid with CVVH
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions; can likely restart today
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, who was admitted for MSSA endocarditis with complications of ARF and apparent AIN, CHB, and torsades, and leukocytoclastic dermatitis on skin biopsy. He is currently in the ICU with respiratory distress, hypoxemia, and hemoptysis concerning for DAH. He is intubated and ventilated, and has been receiving broad-spectrum antibiotics for HAP and MSSA bacteremia. His renal function has improved with CVVH, and his hematuria has decreased.

Potential Medical Complications:

1. DAH/Hypoxemic Respiratory Failure: The patient's respiratory status is improving, but he is still at risk for further bleeding and respiratory failure.
2. Acute on Chronic Renal Failure/AIN: The patient's renal function is improving, but he is still at risk for further kidney damage and AIN.
3. Hemoptysis: The patient's hemoptysis is likely due to DAH, but further investigation is needed to determine the cause.
4. Leukoclastic Dermatitis: The patient's skin rash is improving, but he is still at risk for further skin damage and complications.
5. Bacteremia: The patient has a high-grade MSSA bacteremia and is at risk for further sepsis and complications.
6. Atrial Fibrillation/Complete Heart Block: The patient's cardiac rhythm is currently stable, but he is at risk for further arrhythmias and complications.
7. Anemia: The patient's anemia is likely due to pulmonary hemorrhage, but further investigation is needed to determine the cause.
8. CAD: The patient's CAD is stable, but he is at risk for further complications and thrombosis.
9. s/p AVR: The patient's AVR is stable, but he is at risk for further complications and abscess formation.
10. Hypertension: The patient's hypertension is being managed, but he is at risk for further complications and organ damage.
11. Hyperglycemia: The patient's hyperglycemia is being managed, but he is at risk for further complications and organ damage.
12. Mental Status: The patient's mental status is stable, but he is at risk for further complications and delirium.

Recommendations:

1. Continue to monitor the patient's respiratory status and adjust ventilation as needed.
2. Continue to manage the patient's renal function and AIN with CVVH and steroids.
3. Continue to investigate the cause of the patient's hemoptysis and DAH.
4. Continue to manage the patient's skin rash and dermatitis with topical steroids and antibiotics.
5. Continue to manage the patient's bacteremia with broad-spectrum antibiotics.
6. Continue to manage the patient's cardiac rhythm and arrhythmias with antiarrhythmic medications.
7. Continue to monitor the patient's anemia and adjust transfusions as needed.
8. Continue to manage the patient's CAD and AVR with antiplatelet agents and anticoagulants.
9. Continue to manage the patient's hypertension and hyperglycemia with antihypertensive medications and insulin.
10. Continue to monitor the patient's mental status and adjust sedation as needed.

ICU Care:

1. Nutrition: The patient is receiving IV fluids and nutrition, and his diet will be adjusted as needed.
2. Glycemic Control: The patient's blood glucose levels will be monitored and adjusted with insulin as needed.
3. Lines: The patient has a PICC line, arterial line, and dialysis catheter in place.
4. Prophylaxis: The patient is receiving prophylaxis for DVT, stress ulcer, and VAP.
5. Comments: The patient's code status is full code, and his disposition is pending clinical improvement."
182149.0,283460,2128-02-01 07:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions. Draining thin secretions from lung that are moderately
   blood, like light red wine; suctions have cleared in early AM.
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles; improved
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  Soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with improved red appearance.
   Ext: warm, well perfused; Edema much improved and appears dry; Hands
   also look dry; non-blanching rash over lower extremity improving;
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given secretions
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   # Volume Status
   Patient appears overall volume depleted on exam findings. This explains
   hemoconcentration seen on lab values.
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Trend fever curve
   - Follow up blood cultures
   - Continue to follow
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Copious secretions in the morning with blood, like Framboise Lambic,
   then cleared and reduced later over the day
   - Very comfortable on vent and lightly sedated
   - Continue 30 mg prednisone for AIN
   - Continued heparin with goal PTT 50-60 given St. Jude valve (wanted to
   see if bleeding might stop on this low level of anticoagulation given
   risk of valve)
   - No more pathology
   - Rheum. want taper of steroids, and will likely be happy with AIN
   level treatment.
   - CVVH at 380 this a.m. with 4.7 L off yesterday (Renal want us to
   continue to take off until pressure drops or labs contract given
   possible role of pulmonary edema in DAH).
   - Vancomycin trough 20
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2128-1-31**] 03:00 PM
   Cefipime - [**2128-2-1**] 12:12 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl - 40 mcg/hour
   Calcium Gluconate (CRRT) - 1 grams/hour
   Heparin Sodium - 1,150 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-1-31**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-1**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.7
C (98
   Tcurrent: 35.8
C (96.5
   HR: 75 (75 - 76) bpm
   BP: 108/46(67) {96/46(66) - 150/64(93)} mmHg
   RR: 23 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 2 (-4 - 313)mmHg
   Total In:
                                                                  6,406 mL
                                                                  1,163 mL
   PO:
   TF:
                                                                    720 mL
                                                                    180 mL
   IVF:
                                                                  5,196 mL
                                                                    953 mL
   Blood products:
   Total out:
                                                                 11,115 mL
                                                                  2,730 mL
   Urine:
                                                                    541 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -4,709 mL
                                                                 -1,567 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 498 (343 - 572) mL
   PS : 0 cmH2O
   RR (Spontaneous): 15
   PEEP: 5 cmH2O
   FiO2: 40%
   RSBI: 33
   PIP: 11 cmH2O
   SpO2: 97%
   ABG: 7.37/35/135/18/-3
   Ve: 9.1 L/min
   PaO2 / FiO2: 338
   Physical Examination
   General: Intubated, moderately sedated, but able to interact and follow
   instructions. Draining thin secretions from lung that are moderately
   blood, like light red wine; suctions have cleared in early AM.
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Bilateral expiratory rhonchi and coarse crackles; improved
   CV: Regular normal S1 + S2, +mechanical click.
   Abdomen:  Soft, non-tender, non-distended, bowel sounds present, no
   rebound tenderness or guarding, no organomegaly
   GU: Foley in place with improved red appearance.
   Ext: warm, well perfused; Edema much improved and appears dry; Hands
   also look dry; non-blanching rash over lower extremity improving;
   Neuro: Sedated but rousable and able to interact meaningfully.
   Spontaneously moving all limbs, CNs II-XII intact (within limit of exam
   in intubated patient).
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   389 K/uL
   12.6 g/dL
   201 mg/dL
   1.4 mg/dL
   18 mEq/L
   5.1 mEq/L
   35 mg/dL
   104 mEq/L
   136 mEq/L
   40.6 %
   20.9 K/uL
        [image002.jpg]
                             [**2128-1-31**]  04:30 AM
                             [**2128-1-31**]  06:21 AM
                             [**2128-1-31**]  10:29 AM
                             [**2128-1-31**]  10:38 AM
                             [**2128-1-31**]  04:08 PM
                             [**2128-1-31**]  04:21 PM
                             [**2128-1-31**]  09:54 PM
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
   WBC
   20.9
   Hct
   34.2
   37.7
   40.6
   Plt
   317
   389
   Cr
   1.2
   1.2
   1.4
   TCO2
   32
   28
   29
   24
   24
   21
   Glucose
   162
   253
   170
   201
   Other labs: PT / PTT / INR:14.7/57.4/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.8 mmol/L, LDH:333 IU/L,
   Ca++:9.2 mg/dL, Mg++:2.5 mg/dL, PO4:2.4 mg/dL
   [**2-1**] CXR
 Final read pending; Multifocal opacification stable to
   improved by our read
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; currently hospitalized
   for MSSA endocarditis with complications of ARF and apparent AIN, CHB
   and torsades, and leukocytoclastic dermatitis on skin biopsy, now
   transferred to MICU with respiratory distress, hypoxemia, and
   hemoptysis concerning for DAH.
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation
   Maintain intubation and ventilation for now given continued secretions
   during the day yesterday. Secretions had improved throughout the night,
   and can consider extubation later this pm. Hypoxemic respiratory
   failure has largely resolved - was likely due to pulmonary edema and
   diffuse alveolar hemorrhage. The etiology of hemorrhage is unclear.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Continue to follow up renal biopsy results from [**1-29**]
   - SBT and consider extubation this PM given improved secretions and
   lesser chance of hemorrhage without cough and management of respiratory
   parameters
   - Continue to appreciate input of Rheumatology (want to taper
   steroids), Renal (steroids for AIN only), Dermatology (topical
   steroid).
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue Heparin gtt with PTT goal 50-70
   - Hold ASA for now given secretions
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   # Volume Status
   Patient appears overall volume depleted on exam findings. This explains
   hemoconcentration seen on lab values.
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Trend fever curve
   - Follow up blood cultures
   - Continue to follow
   #. Hemoptysis
   Discussion above pertains. Likely little further benefit and possible
   harm, so hold bronchoscopy for now.
   #. Acute on Chronic Renal Failure/AIN
   Cr 1.5 on presentation; up to 3.4, now 1.2 on CVVH. DDx includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Continue Prednisone 30mg to treat AIN (will check with Renal, but
   likely will need for 4 weeks; start date [**2-1**])
   - Continue to renally dose medications
   - Plan to discontinue CVVH
 will need to get in touch with Renal
   - Continue to follow up renal biopsy results from [**1-29**]
   - Continue to follow urine output
   - Continue to follow Renal recommendations
   #. Hematuria
   Likely secondary to biopsy in context of said coagulopathy. Will need
   to monitor given danger period following biopsy is about two weeks.
   Likely too bloody for vasculitic cause.
   - Ask Renal if benefit to spinning when so frankly bloody (surely not
   just due to vasculitis given amount, precipitant (biopsy), and no
   vasculitis on biopsy) (also send UA but may not be helpful for the same
   reason).
   - Continue to follow urine output and if hematuria
   - Consider irrigation if reduction in urine output, suprapubic pain or
   residual volume
   # Leukoclastic Dermatitis
   Is recovering. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. Improving overall. See
   discussion above for relationship to unifying diagnosis.
   - Continue steroids as above.
   - Continue to follow Derm recommendations
   #. Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue to repeat blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow ID recommendations
   # Atrial Fibrillation/Complete Heart Block
   History this admission of CHB (as well as torsades, thought due to
   FQs), now s/p screw-in pacemaker that is presently ventricularly
   pacing.
   - Continue Heparin as above
   - EP following - plan for 2 months of this pacer before likely
   permanent pacer.
   # Anemia
   Hematocrit has been stable. Now with pulmonary hemorrhage likely. If
   diffuse vasculitis or actually secondary to primary coagulopathy then
   need to maintain suspicion for other sites of blood loss, including GI
   tract. Patient is consented for blood products.
   - Continue to check Hematocrit q8
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # CAD
   S/p CABG and with DES x3 in one graft. Given coagulopathy, is off
   anticoagulants. [**Month (only) 60**] be some concern for increased thrombosis risk in
   coming days, but have not choice given severity of presentation. We
   will need to revisit this when diagnosis is cleared and natural history
   of this presentation clearer.
   - Continue statin
   - Hold ASA for now given bloody secretions
   - Holding ACE in the setting of renal failure
   - Holding BB for now
   - Continue Heparin as above
   #. s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF).
   - Heparin as above, transition to coumadin if possible
   - CT surgery consult if clinical condition worsens and concerning for
   abscess.
   - Consider TEE when stabilized and acute issues under control
 patient
   is actually receiving appropriate treatment now anyway.
   #. Hypertension.
   - Holding anti-HTNs in setting of bleeding as above.
   #. Hyperglycemia
   In the context of steroids. When stabilized on 30 mg prednisone daily
   will adjust for tighter control.
   #. Mental Status
   Lightly sedated. Will lighten slightly further today.
   # FEN: No IVF, replete electrolytes, TF recs.
   # Prophylaxis: boots, H2R blocker; bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Communication: wife: [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**]
   (daughter and nurse) [**Telephone/Fax (1) 11366**] - need to verify who is HCP.
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and s/p mechanical AVR, currently hospitalized for MSSA endocarditis with complications of ARF, AIN, CHB, and torsades, and leukocytoclastic dermatitis on skin biopsy. He is currently intubated and ventilated due to respiratory distress, hypoxemia, and hemoptysis concerning for DAH. His secretions have improved throughout the night, and he is a candidate for extubation later today.

Potential Medical Complications:

1. DAH: The patient's hemoptysis and respiratory distress are concerning for DAH, which is a life-threatening condition. The etiology of hemorrhage is unclear, but it may be related to vasculitic or autoimmune processes, coagulopathy, or the effect of pulmonary edema in the context of coagulopathy.
2. AIN: The patient's renal failure and urinary eosinophils are consistent with AIN, which is a potential complication of his endocarditis treatment. The patient is receiving prednisone to treat AIN, and his renal function is being closely monitored.
3. Coagulopathy: The patient's bleeding diathesis is a concern, particularly given his history of cardiac surgery and mechanical AVR. He is receiving heparin to prevent thrombosis, but his INR is likely to be higher than the target range due to his other risks.
4. Hypoxemic Respiratory Failure: The patient's respiratory distress and hypoxemia are concerning for hypoxemic respiratory failure, which may be related to his DAH or other underlying conditions.
5. Cardiac Complications: The patient's history of cardiac surgery and mechanical AVR makes him at risk for cardiac complications, including increased thrombosis risk and arrhythmias.
6. Renal Failure: The patient's renal function is compromised, and he is at risk for further decline in renal function if not managed properly.
7. Leukocytoclastic Dermatitis: The patient's skin biopsy revealed leukocytoclastic dermatitis, which is a potential complication of his endocarditis treatment. His skin lesions are improving, but he will need to continue to receive steroids and follow-up with dermatology.
8. Bacteremia: The patient's high-grade MSSA bacteremia is a concern, and he will need to receive antibiotics for a full 8-week course to prevent relapse.
9. Atrial Fibrillation/Complete Heart Block: The patient's history of atrial fibrillation and complete heart block makes him at risk for cardiac complications, including increased thrombosis risk and arrhythmias.

Recommendations:

1. Continue to monitor the patient's respiratory status and consider extubation if his secretions improve and his respiratory parameters are stable.
2. Continue to manage the patient's coagulopathy with heparin and monitor his INR closely.
3. Continue to treat the patient's AIN with prednisone and monitor his renal function closely.
4. Continue to manage the patient's cardiac complications, including his history of cardiac surgery and mechanical AVR.
5. Continue to monitor the patient's renal function and consider dialysis if necessary.
6. Continue to follow up with dermatology to monitor the patient's skin lesions and adjust his treatment as necessary.
7. Continue to manage the patient's bacteremia with antibiotics and monitor for signs of relapse.
8. Continue to monitor the patient's atrial fibrillation and complete heart block and adjust his treatment as necessary."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of CAD, s/p CABG, and mechanical AVR, admitted with MSSA bacteremia, torsades, and ARF likely secondary to AIN. He was intubated and required CVVH and mechanical ventilation. The patient was extubated successfully and is currently on oxygen therapy via nasal cannula. His condition is complicated by DAH, hypoxemic respiratory failure, and hemoptysis. He has a petechial rash on his lower extremities, which is improving.

The patient's lab results show worsening renal function, with increasing BUN and Cr levels, and decreasing HCO3 levels. His WBC count is elevated, and his platelet count is decreasing. His electrolyte levels are abnormal, with hypokalemia and hypophosphatemia.

The patient's medications include Cefepime, Vancomycin, Famotidine, Lorazepam, and Prednisone. He is also receiving Heparin and CVVH.

Potential medical complications:

1. Flash pulmonary edema: The patient's condition is complicated by DAH and hypoxemic respiratory failure, which may lead to flash pulmonary edema. CVVH or emergent HD may be necessary to manage this complication.
2. Worsening renal function: The patient's renal function is worsening, which may require further intervention, such as HD or CRRT.
3. Infection: The patient has MSSA bacteremia, which may lead to sepsis and organ failure.
4. Bleeding: The patient has a petechial rash on his lower extremities, which may indicate bleeding diathesis. He is also receiving anticoagulation therapy, which may increase the risk of bleeding.
5. Respiratory failure: The patient's respiratory failure may worsen, requiring further intervention, such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO).
6. Cardiovascular complications: The patient's history of CAD and mechanical AVR may increase the risk of cardiovascular complications, such as heart failure, arrhythmias, or myocardial infarction.
7. Neurological complications: The patient's history of torsades and AIN may increase the risk of neurological complications, such as seizures or encephalopathy.

Assessment and plan:

The patient's condition is complicated and requires close monitoring and management. The plan is to continue CVVH and mechanical ventilation, and to manage his bleeding and infection. Further interventions, such as HD or CRRT, may be necessary to manage his worsening renal function. The patient's medications will be continued and adjusted as necessary."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image003.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image003.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - No new CXR, culture data.
   - Renal biopsy results continue to be pending.
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for possible HD today per Renal recommendations
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations
   will likely need for 4-6 weeks; start date [**2-1**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime and Vancomycin
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S
   - Continue Protonix while being aware that PPI may also cause AIN
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, continue tube feeds per
   recommendation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient, a 76-year-old male, is a complex case with multiple comorbidities, including coronary artery disease (CAD), mechanical aortic valve replacement (AVR), atrial fibrillation (Afib), and chronic kidney disease (CKD). He was admitted with methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia, torsades de pointes, and acute kidney injury (AKI) likely secondary to allergic interstitial nephritis (AIN). He has undergone several interventions, including mechanical ventilation, continuous venovenous hemofiltration (CVVH), and renal biopsy.

The patient's current status is as follows:

* Respiratory: Extubated and stable, with improving lung sounds and decreased secretions.
* Cardiac: Stable with ventricular pacing, and anticoagulation therapy ongoing.
* Renal: Worsening renal function, with increasing blood urea nitrogen (BUN) and creatinine (Cr) levels, and a need for hemodialysis (HD).
* Hematology: Anemia, with a stable hematocrit (Hct) level, and consent for blood products.
* Dermatology: Leukoclastic dermatitis, thought to be related to Nafcillin or Allopurinol, and improving with steroids.
* Infections: MSSA bacteremia, with a high-grade infection, and ongoing antibiotic therapy.

Potential Medical Complications:

1. Flash pulmonary edema: Given the patient's history of pulmonary edema and diffuse alveolar hemorrhage, there is a risk of flash pulmonary edema, which could worsen respiratory function and require emergent CVVH or HD.
2. Worsening renal function: The patient's BUN and Cr levels are increasing, and he may require HD to manage his renal function.
3. Bleeding: The patient has a history of bleeding, including hematuria, and may require close monitoring and prophylactic measures to prevent further bleeding.
4. Infection: The patient has ongoing MSSA bacteremia and may require prolonged antibiotic therapy to manage the infection.
5. Cardiovascular complications: The patient has a history of CAD, AVR, and Afib, which may increase his risk of cardiovascular complications, such as myocardial infarction or stroke.

Plan:

1. Continue to monitor the patient's respiratory, cardiac, and renal function closely.
2. Manage the patient's bleeding risk with prophylactic measures, such as Heparin and platelet transfusions.
3. Continue antibiotic therapy for MSSA bacteremia and monitor for signs of infection.
4. Consider HD to manage the patient's worsening renal function.
5. Monitor the patient's anemia and consider blood transfusions if necessary.
6. Continue to follow the patient's dermatological condition and adjust treatment as needed.
7. Consider a CT surgery consult if the patient's clinical condition worsens and there is concern for an abscess."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, who underwent coronary artery bypass grafting (CABG) and mechanical aortic valve replacement (AVR). He was admitted with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, torsades de pointes, and acute kidney injury (AKI). The patient was treated with vancomycin and cefepime, and was started on continuous venovenous hemofiltration (CVVH) due to AKI. He was extubated successfully and is currently off mechanical ventilation.

The patient's laboratory results show worsening renal function, with increasing blood urea nitrogen (BUN), creatinine (Cr), and bicarbonate (HCO3) levels. The patient's hemoglobin (Hb) level is 13.0 g/dL, and his white blood cell (WBC) count is 20.9 x 10^9/L. His electrolyte levels are within normal limits, except for a slightly elevated potassium (K+) level.

The patient's physical examination reveals a supple neck, bilateral breath sounds, and a regular heart rhythm with a mechanical click. His abdomen is soft, and he has a petechial rash on his lower extremities.

The patient's medications include vancomycin, cefepime, heparin, famotidine, and lorazepam.

Potential Medical Complications:

1. Worsening renal function: The patient's BUN, Cr, and HCO3 levels are increasing, indicating worsening renal function. This may lead to further fluid overload, electrolyte imbalances, and acidosis.
2. Infection: The patient has MSSA bacteremia and may be at risk for further infections, such as pneumonia or sepsis.
3. Bleeding: The patient is receiving anticoagulation therapy with heparin, which may increase his risk of bleeding.
4. Hypertension: The patient's blood pressure is elevated, and he may be at risk for further hypertension-related complications, such as cardiac failure or stroke.
5. Hyperglycemia: The patient's blood glucose level is elevated, and he may be at risk for further hyperglycemic complications, such as ketoacidosis or hyperosmolar nonketotic syndrome.
6. Anemia: The patient's hemoglobin level is low, and he may be at risk for further anemia-related complications, such as fatigue, shortness of breath, or decreased exercise tolerance.
7. Pulmonary edema: The patient has a history of pulmonary edema, and may be at risk for further fluid overload or cardiac failure.

Recommendations:

1. Continue to monitor the patient's renal function and adjust his medications accordingly.
2. Continue to treat the patient's infection with vancomycin and cefepime.
3. Monitor the patient's bleeding risk and adjust his anticoagulation therapy as needed.
4. Monitor the patient's blood pressure and adjust his antihypertensive medications as needed.
5. Monitor the patient's blood glucose level and adjust his insulin therapy as needed.
6. Monitor the patient's anemia and consider transfusing him if necessary.
7. Monitor the patient's pulmonary edema and adjust his fluid management accordingly."
182149.0,283460,2128-02-02 08:09:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 INVASIVE VENTILATION - STOP [**2128-2-1**] 11:17 AM
   - Patient extubated succesfully during early morning; did well
   throughout the day
   - We removed the stitch from the derm skin biopsy site.
   - Rheumatology notes clear clinical improvement and recommends
   following up with the final result of the renal biopsy.
   - Renal recommends to continue steroids, to stop CVVH, and to evaluate
   and plan for possible HD on Monday. They also recommend to give
   Vancomycin with HD, to reduce Cefepime to 1gm q24 and to stop
   Sucralfate (aluminum toxicity). We ordered for a trough to follow up in
   AM.
   - Patient with worsening BUN, Cr, HCO3 through evening; plan to manage
   in AM with HD per renal.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-1**] 01:30 PM
   Infusions:
   Heparin Sodium - 1,050 units/hour
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-1**] 08:00 AM
   Lorazepam (Ativan) - [**2128-2-1**] 09:48 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-2**] 06:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 36.1
C (97
   Tcurrent: 35.7
C (96.2
   HR: 75 (75 - 78) bpm
   BP: 258/255(257) {90/46(61) - 258/255(257)} mmHg
   RR: 26 (15 - 31) insp/min
   SpO2: 95%
   Heart rhythm: V Paced
   Wgt (current): 73.7 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 4 (-5 - 8)mmHg
   Total In:
                                                                  2,382 mL
                                                                     71 mL
   PO:
   TF:
                                                                    180 mL
   IVF:
                                                                  2,112 mL
                                                                     71 mL
   Blood products:
   Total out:
                                                                  3,944 mL
                                                                     90 mL
   Urine:
                                                                    150 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,562 mL
                                                                    -19 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: [[**Doctor First Name **]: CPAP/PSV :[**Doctor First Name **]]
   Vt (Spontaneous): 571 (571 - 571) mL
   PS : 5 cmH2O
   RR (Spontaneous): 28
   PEEP: 5 cmH2O
   FiO2: 50%
   PIP: 6 cmH2O
   SpO2: 95%
   ABG: 7.37/26/78/17/-8
   Ve: 14.1 L/min
   PaO2 / FiO2: 195
   Physical Examination
   General: Extubated; reduced but continued light red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   363 K/uL
   13.0 g/dL
   152 mg/dL
   3.2 mg/dL
   17 mEq/L
   5.4 mEq/L
   84 mg/dL
   105 mEq/L
   139 mEq/L
   42.3 %
   22.4 K/uL
        [image002.jpg]
                             [**2128-1-31**]  10:12 PM
                             [**2128-2-1**]  03:45 AM
                             [**2128-2-1**]  04:00 AM
                             [**2128-2-1**]  08:16 AM
                             [**2128-2-1**]  12:02 PM
                             [**2128-2-1**]  04:41 PM
                             [**2128-2-1**]  07:50 PM
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
   WBC
   20.9
   22.4
   Hct
   40.6
   40.8
   42.3
   Plt
   389
   363
   Cr
   1.4
   2.4
   2.7
   3.2
   TCO2
   24
   21
   18
   17
   16
   16
   Glucose
   [**Telephone/Fax (3) 11399**]52
   Other labs: PT / PTT / INR:15.1/47.7/1.3, ALT / AST:[**2-4**], Alk Phos / T
   Bili:104/1.7, Differential-Neuts:92.3 %, Lymph:6.0 %, Mono:1.6 %,
   Eos:0.1 %, Fibrinogen:407 mg/dL, Lactic Acid:0.9 mmol/L, LDH:333 IU/L,
   Ca++:9.6 mg/dL, Mg++:2.7 mg/dL, PO4:4.8 mg/dL
   - CXR appears improved on left, slight prominence of opacity on right
   - No new culture data
   - Renal biopsy results continue to be pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. Also with large diuresis off diuretics. DDx includes AIN due
   to Nafcillin (also identical pathophysiology with concomitant rash
   see below), although Allopurinol and Warfarin can also less frequently
   (and much less likely in this case) produce this effect. Renal biopsy
   without changes consistent with AIN, but already given a few days of
   high-dose steroids. Awaiting final renal pathology results and
   evaluation. Evidence for AIN includes white cell casts, worsened renal
   function and urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   continues to have large UOP, likely contributing to his continued
   hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male who was admitted with MSSA bacteremia, torsades, and acute renal failure. He underwent mechanical aortic valve replacement and coronary artery bypass grafting (CABG) and is currently in the intensive care unit (ICU). The patient was extubated successfully and is currently on nasal cannula oxygen. His vital signs are stable, with a temperature of 36.1°C, heart rate of 75 beats per minute, and blood pressure of 258/255 mmHg. He has a petechial rash on his lower extremities, which is improving.

The patient has been diagnosed with acute on chronic renal failure, likely secondary to AIN, and is currently managed with continuous venovenous hemofiltration (CVVH) and likely hemodialysis (HD) starting today. He has also been diagnosed with multifactorial diffuse alveolar hemorrhage (DAH), which is currently stable, and is being treated with broad-spectrum antibiotics for MSSA bacteremia.

The patient has a history of atrial fibrillation, complete heart block, and is currently being paced ventricularly. He has also been diagnosed with anemia, likely secondary to hemoconcentration, and is being monitored for bleeding.

Potential Medical Complications:

1. Flash pulmonary edema: Given the patient's history of DAH and pulmonary edema, there is a risk of flash pulmonary edema during the next 24 hours. The patient's respiratory status should be closely monitored, and CVVH or HD may need to be restarted if this occurs.
2. Worsening renal function: The patient's renal function is currently worsening, and there is a risk of further decline. The patient's renal biopsy results are pending, and the patient will need to be closely monitored for signs of worsening renal function.
3. Hematuria: The patient has been experiencing hematuria, likely secondary to biopsy, and will need to be closely monitored for signs of worsening bleeding.
4. Anemia: The patient's anemia is likely secondary to hemoconcentration, and he will need to be closely monitored for signs of worsening anemia.
5. Infection: The patient has a history of MSSA bacteremia and is currently being treated with broad-spectrum antibiotics. There is a risk of infection, and the patient's blood cultures should be closely monitored.
6. Bleeding: The patient has a history of bleeding, and there is a risk of further bleeding. The patient's anticoagulation therapy should be closely monitored, and the patient should be closely monitored for signs of bleeding.

Recommendations:

1. Continue to monitor the patient's respiratory status and be prepared to restart CVVH or HD if flash pulmonary edema occurs.
2. Continue to monitor the patient's renal function and be prepared to adjust his treatment plan if his renal function worsens.
3. Continue to monitor the patient's hematuria and be prepared to adjust his treatment plan if his bleeding worsens.
4. Continue to monitor the patient's anemia and be prepared to adjust his treatment plan if his anemia worsens.
5. Continue to monitor the patient's infection and be prepared to adjust his treatment plan if his infection worsens.
6. Continue to monitor the patient's bleeding and be prepared to adjust his treatment plan if his bleeding worsens.
7. Continue to follow the patient's progress and be prepared to adjust his treatment plan as needed."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 4L
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukocytoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA in 48 hours on [**2-5**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, thin liquids at this time;
   continue to follow speech/swallow recommendations
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line; will continue to discuss need for
   permanent dialysis line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement; likely today to [**Hospital1 2259**]
   with telemetry
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 4L
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukocytoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60; transition to coumadin when more
   certain hemoptysis/hematuria resolving
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA in 48 hours on [**2-5**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, thin liquids at this time;
   continue to follow speech/swallow recommendations
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line; will continue to discuss need for
   permanent dialysis line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement; likely today to [**Hospital1 2259**]
   with telemetry
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 76-year-old male with a history of coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation. He was admitted with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, torsades de pointes, and acute kidney injury (AKI). He has been managed with continuous veno-venous hemofiltration (CVVH) and is currently undergoing hemodialysis (HD). The patient has also been treated with antibiotics, steroids, and anticoagulants.

The patient's current condition is stable, with improved renal function and decreased serum creatinine levels. His blood pressure is stable, and his oxygen saturation is 96%. He has a petechial rash on his legs, which is improving. His lungs are clear, and his heart rhythm is ventricularly paced.

The patient's labs show elevated white blood cell count, platelet count, and troponin-T levels. His electrolyte levels are within normal range, except for potassium, which is slightly elevated. His blood urea nitrogen (BUN) and creatinine levels are elevated, indicating kidney dysfunction.

The patient's medical history includes coronary artery disease, mechanical aortic valve replacement, and atrial fibrillation. He has a history of bleeding and has been taking anticoagulants. He has also been taking steroids and antibiotics for his current infection.

Potential Medical Complications:

1. Flash pulmonary edema: The patient's history of atrial fibrillation and mechanical aortic valve replacement increases his risk of developing flash pulmonary edema. This condition can lead to respiratory failure and death.
2. Vasculitis: The patient's petechial rash and hematuria suggest the possibility of vasculitis, which can cause organ damage and failure.
3. Endocarditis: The patient's history of MSSA bacteremia and atrial fibrillation increases his risk of developing endocarditis, which can lead to valve damage and failure.
4. Renal failure: The patient's AKI and decreased renal function increase his risk of developing renal failure, which can lead to electrolyte imbalances, acidosis, and death.
5. Bleeding: The patient's history of bleeding and anticoagulant use increases his risk of bleeding, which can lead to hypovolemic shock and death.
6. Infection: The patient's history of MSSA bacteremia and antibiotic use increases his risk of developing secondary infections, which can lead to sepsis and death.

Recommendations:

1. Continue to monitor the patient's renal function and adjust his fluid and electrolyte management accordingly.
2. Continue to manage the patient's bleeding risk with anticoagulants and monitor his hemoglobin levels.
3. Continue to monitor the patient's cardiac status and adjust his anticoagulant therapy accordingly.
4. Continue to monitor the patient's respiratory status and adjust his oxygen therapy accordingly.
5. Continue to monitor the patient's nutritional status and adjust his diet and supplements accordingly.
6. Consider consulting a nephrologist or intensivist for further management of the patient's AKI and other medical complications."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 68-year-old male who was admitted to the ICU with a diagnosis of sepsis, acute respiratory failure, and acute renal failure. The patient has a history of atrial fibrillation and has been treated with antibiotics for bacterial endocarditis. The patient's vital signs are stable, with a temperature of 37.9°C, heart rate of 75 bpm, and blood pressure of 129/75 mmHg. The patient's respiratory status is improving, with an SpO2 of 96% on nasal cannula oxygen. The patient's neurological status is also stable, with an altered mental status and spontaneous movement of all extremities.

The patient experienced chest pain during dialysis, which resolved when the dialysis was stopped. The patient's laboratory results show elevated white blood cell count, anemia, and hyperglycemia. The patient's blood cultures are positive for bacteria, and the patient is at risk for bacteremia.

Potential medical complications that can arise:

1. Sepsis: The patient's blood cultures are positive for bacteria, and the patient is at risk for developing sepsis.
2. Bacteremia: The patient has a history of bacteremia, and the patient's blood cultures are positive for bacteria, which increases the risk of developing bacteremia.
3. Acute kidney injury: The patient has acute renal failure, and the patient's creatinine levels are elevated.
4. Respiratory failure: The patient has acute respiratory failure, and the patient's oxygen saturation is low.
5. Cardiac complications: The patient has a history of atrial fibrillation, and the patient's cardiac status is at risk.
6. Neurological complications: The patient has altered mental status, and the patient's neurological status is at risk.
7. Infection: The patient has a history of infection, and the patient's immune system is compromised, which increases the risk of developing another infection.
8. Hyperglycemia: The patient has hyperglycemia, and the patient's blood glucose levels are elevated.
9. Hypotension: The patient has hypotension, and the patient's blood pressure is low.
10. Hemorrhage: The patient has a history of bleeding, and the patient's blood products are at risk of being depleted.

Recommendations:

1. Continue antibiotics to treat bacterial endocarditis and sepsis.
2. Monitor the patient's vital signs closely for any changes.
3. Monitor the patient's laboratory results for any changes in the patient's condition.
4. Continue dialysis to manage the patient's acute renal failure.
5. Continue respiratory support to manage the patient's acute respiratory failure.
6. Monitor the patient's neurological status closely for any changes.
7. Monitor the patient's cardiac status closely for any changes.
8. Consider administering stress ulcer prophylaxis to prevent gastrointestinal bleeding.
9. Consider administering prophylaxis for deep vein thrombosis to prevent thrombosis.
10. Consider administering prophylaxis for ventilator-associated pneumonia to prevent infection."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Cr, BUN and bicarbonate all suggestive of progressively worsening renal
   function. DDx includes AIN due to Nafcillin (also identical
   pathophysiology with concomitant rash
 see below), although
   Allopurinol and Warfarin can also less frequently (and much less likely
   in this case) produce this effect. Renal biopsy without changes
   consistent with AIN, but already given a few days of high-dose
   steroids. Awaiting final renal pathology results and evaluation.
   Evidence for AIN includes white cell casts, worsened renal function and
   urinary eosinophils.
   - Obtain urine electrolytes
   - Plan for HD today with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg)
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   CVVH discontinued [**2-1**] as patient appeared volume depleted on exam. He
   still had large volume out from CVVH yesterday, likely contributing to
   his continued hemoconcentration seen on lab values.
   - Plan for possible HD today per Renal recommendations
   - Trend fever curve
   - Obtain UA
   - Follow up blood cultures; obtain blood cultures today
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan to
   restart CVVH or emergent HD pending renal recommendations today should
   such an event occur. Hypoxemic respiratory failure has largely resolved
   - was likely due to pulmonary edema and diffuse alveolar hemorrhage.
   The etiology of hemorrhage is unclear and likely multifactorial.
   Differential diagnoses include vasculitic and autoimmune processes,
   coagulopathy, or the effect of pulmonary edema in the context of
   coagulopathy. Vaculitis was initially thought most likely, given renal
   failure, rash and pulmonary hemorrhage, but investigations for this
   have been relatively unimpressive: ESR from 15 to 100s now, but
   negative [**Doctor First Name 1205**], ANCA, anti-GBM and unimpressive pathology of skin and
   kidney, although the final read of the latter is pending. Patient
   clinically improving s/p diuresis and steroids and HCT stable.
   Vasculitis now unlikely enough to taper steroids to level for treatment
   of AIN along. Nonetheless, ANCA may not be positive in early disease
   and should be repeated in three to four weeks. Possibility of worsened
   MR and pulmonary edema, but unlikely given echo three days ago.
   - Obtain CXR this AM
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent CVVH /HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major, 3 minor)
   for endocarditis. TTE did not reveal vegetations, but sensitivity
   likely low. Nonetheless, given AVR and concern, ID recommends
   antibiotics for a full 8 week course. Switched from Nafcillin/Rifampin
   to Vancomycin [**1-17**] due to question of AIN.
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Follow up blood cultures
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Likely secondary to biopsy in context of coagulopathy. Will need to
   monitor given danger period following biopsy is about two weeks. Likely
   too bloody for vasculitic etiologic. Appears overall to be improving
   per nursing. [**Month (only) 60**] consider asking Renal if there is a benefit to
   spinning urine when it is so frankly bloody. Also, may consider
   irrigation for blood clots if there is a reduction in urine output,
   suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease, mechanical aortic valve replacement, atrial fibrillation, and recent mechanical aortic valve replacement. He was admitted with methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia and endocarditis, and has been diagnosed with acute kidney injury (AKI), likely secondary to antibiotic-induced nephrotoxicity.

The patient's current condition is as follows:

* Chest pain during dialysis, which resolved when dialysis was stopped
* Diffuse ST-segment elevation on ECG
* Hemodynamic instability, with a blood pressure of 129/75 mmHg and a heart rate of 75 beats per minute
* Respiratory support with nasal cannula oxygen and mechanical ventilation
* Abnormal laboratory results, including elevated creatinine, blood urea nitrogen, and bicarbonate levels, as well as anemia and leukocytosis
* Presence of petechial rash on the lower extremities, which is improving

Potential medical complications that can arise from the patient's current condition include:

* Flash pulmonary edema, which could be exacerbated by the patient's underlying respiratory failure and hemodynamic instability
* Worsening of the patient's renal function, which could lead to further electrolyte imbalances and acidosis
* Development of bleeding complications, such as hematuria or gastrointestinal bleeding, due to the patient's coagulopathy and recent biopsies
* Infection, including bacteremia and endocarditis, which could be complicated by the patient's immunosuppressed state and underlying cardiac disease
* Cardiovascular complications, such as cardiac arrhythmias or heart failure, which could be exacerbated by the patient's underlying coronary artery disease and mechanical aortic valve replacement

The patient's treatment plan includes:

* Continued antibiotic therapy for MSSA bacteremia and endocarditis
* Hemodialysis to manage the patient's acute kidney injury and electrolyte imbalances
* Steroids to treat the patient's leukocytoclastic vasculitis and petechial rash
* Heparin therapy to prevent thrombosis and bleeding complications
* Monitoring of the patient's cardiac function and rhythm, including the use of a temporary pacemaker
* Close monitoring of the patient's respiratory and hemodynamic status, including the use of mechanical ventilation and vasopressors as needed."
182149.0,283460,2128-02-03 07:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Some chest pain during dialysis (deep, sharp, [**2128-4-19**], intermittent
   for about 30 minutes total, non-radiating). Stopped dialysis one hour
   early, on O2 BB heparin already, drew enzymes immediately after
   dialysis and clear - will cycle. EKG with diffuse TWI. Did not drop
   pressure during this period, other vitals stable. Resolved when
   dialysis stopped.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2128-2-2**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2128-2-3**] 07:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 78) bpm
   BP: 129/75(86) {105/51(61) - 132/81(90)} mmHg
   RR: 20 (17 - 29) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
    CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    918 mL
                                                                    162 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    678 mL
                                                                    162 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    160 mL
   Urine:
                                                                    300 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    618 mL
                                                                      2 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General: Extubated; reduced but continued dark red secretions
   Neck: Supple, JVD elevation difficult to appreciate given respiratory
   distress and upright positioning and now dialysis line.
   Lungs: Breath sounds similar to yesterday; rales bilateral bases;
   rhonchi worse on right
   CV: Regular, +mechanical click
   Abdomen:  Soft, NT, ND, +BS, no rebound, no guarding
   GU: Foley in place with continued dark appearance
   Ext: Warm, well perfused; Edema much improved and appears dry; Hands
   also look dry;
   Neuro: AOx3, spontaneously moving all extremities
   Skin: Petechial rash lower extremity is improving.
   Labs / Radiology
   290 K/uL
   11.6 g/dL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   [**2-3**] CXR
 Final read pending; appears stable to improved
   [**2-2**] Urine, culture
 Pending
   [**1-29**] Renal biopsy
 Pending
   Assessment and Plan
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   # Acute on Chronic Renal Failure/AIN
   Stable. s/p HD yesterday. Cr, BUN and bicarbonate initially improving.
   FeNa 0.2 likely pre-renal vs acute GN etiologies. DDx also includes AIN
   due to Nafcillin (also identical pathophysiology with concomitant rash
 see below), although Allopurinol and Warfarin can also less
   frequently (and much less likely in this case) produce this effect.
   Renal biopsy without changes consistent with AIN, but already given a
   few days of high-dose steroids. Awaiting final renal pathology results
   and evaluation. Evidence for AIN includes white cell casts, worsened
   renal function and urinary eosinophils.
   - Plan for HD [**2-4**] with Renal
   - Continue to follow Vancomycin trough
   - Continue Prednisone 30mg to treat AIN per Renal recommendations; will
   plan to taper (start date [**2-1**]; 5 days 30mg, 5 days 20mg, 5 days 10mg);
   Renal recommends changing to 20mg on [**2-4**]
   - Continue to renally dose medications
   - Continue to follow UOP
   - Follow up renal biopsy results from [**1-29**]
   - Continue to follow Renal recommendations; appreciate their input
   # Volume Status
   Stable/improving. CVVH discontinued [**2-1**] as patient appeared volume
   depleted on exam. His volume status seems to have stabilized;
   hemoconcentration seems improved.
   - Plan for HD [**2-4**] with Renal
   - Trend fever curve
   - Follow up urine/blood cultures
   # DAH/Hypoxemic Respiratory Failure/Ventilation/Intubation/Hemoptysis
   Stable s/p extubation. Secretion quantity has improved throughout past
   2 days and seems to be stable off of positive pressure from ventilator.
   Concern for flash pulmonary edema during this period
 can plan on
   emergent HD pending renal recommendations today should such an event
   occur. Hypoxemic respiratory failure has largely resolved - was likely
   due to pulmonary edema and diffuse alveolar hemorrhage. The etiology of
   hemorrhage is unclear and likely multifactorial. Differential diagnoses
   include vasculitic and autoimmune processes, coagulopathy, or the
   effect of pulmonary edema in the context of coagulopathy. Vaculitis was
   initially thought most likely, given renal failure, rash and pulmonary
   hemorrhage, but investigations for this have been relatively
   unimpressive: ESR from 15 to 100s now, but negative [**Doctor First Name 1205**], ANCA, anti-GBM
   and unimpressive pathology of skin and kidney, although the final read
   of the latter is pending. Patient clinically improving s/p diuresis and
   steroids and HCT stable. Vasculitis now unlikely enough to taper
   steroids to level for treatment of AIN along. Nonetheless, ANCA may not
   be positive in early disease and should be repeated in three to four
   weeks. Possibility of worsened MR and pulmonary edema, but unlikely
   given echo three days ago.
   - Follow CXR
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow secretions on Heparin
   - Consider emergent HD in the event of flash pulmonary edema
   - Continue to follow Rheumatology, Renal, Dermatology, ID
   recommendations; appreciate their input
   # Leukoclastic Dermatitis
   Overall improving. Thought to be due to Nafcillin or Allopurinol
 case
   reports of Warfarin also, but much less likely. See discussion above
   for relationship to unifying diagnosis.
   - Continue steroids as above
   - Continue to follow Dermatology recommendations; appreciate their
   input
   # Bacteremia
   Stable. High-grade MSSA bacteremia and fulfils Duke Criteria (1 Major,
   3 minor) for endocarditis. TTE did not reveal vegetations, but
   sensitivity likely low. Nonetheless, given AVR and concern, ID
   recommends antibiotics for a full 8 week course. Switched from
   Nafcillin/Rifampin to Vancomycin [**1-17**] due to question of AIN.
   - Follow up blood cultures
   - Continue broad spectrum treatment for HAP, MSSA bacteremia in context
   of AVR
 Cefepime (start date [**1-27**], 8 days total) and Vancomycin (start
   date [**1-7**], 8 weeks total per ID recommendations)
   - Continue to follow ID recommendations; appreciate their input
   # Hematuria
   Stable/improving. Likely secondary to biopsy in context of
   coagulopathy. Will need to monitor given danger period following biopsy
   is about two weeks. Likely too bloody for vasculitic etiologic. Appears
   overall to be improving per nursing. [**Month (only) 60**] consider asking Renal if there
   is a benefit to spinning urine when it is so frankly bloody. Also, may
   consider irrigation for blood clots if there is a reduction in urine
   output, suprapubic pain or residual volume.
   - Continue to follow UOP/hematuria on Heparin
   # Anemia
   Hematocrit has been stable to high likely secondary to
   hemoconcentration. Patient is consented for blood products.
   - Continue to check Hematocrit [**Hospital1 **]
   - Guaiac stool
   - Continue to maintain active T&S (current outdates [**2-2**])
   # Atrial Fibrillation/Complete Heart Block
   CHB this admission (as well as torsades, thought due to FQs), now s/p
   screw-in pacemaker that is presently ventricularly pacing.  EP is
   following and current plan is for 2 months of this temporary pacer
   prior to placing permanent pacer.
   - Continue Heparin gtt PTT goal 50-60
   - Continue to follow EP recommendations; appreciate their input;
   # s/p AVR (St. [**Male First Name (un) 6198**]).  Endocarditis as above. Goal for INR [**2-18**], but
   likely higher in this patient given other risks (AF). Can consider CT
   surgery consult if clinical condition worsens and concerning for
   abscess. Consider TEE when patient further stabilized and acute issues
   under control
 patient is receiving appropriate treatment now anyway.
   - Continue Heparin gtt PTT goal 50-60
   - Transition to coumadin when possible
   # CAD
   s/p CABG with DES x3 in one graft. Have restarted anticoagulation given
   the concern for increased thrombosis risk.
   - Continue Heparin as above
   - Consider restarting ASA given stable Hct; likely tomorrow, [**2-3**]
   - Continue statin
   - Holding ACE in the setting of renal failure
   - Holding BB in the setting of bleed as above
   # Hypertension.
   - Holding antihypertensives in the setting of bleed as above
   # Hyperglycemia
   - ISS in the context of steroids
   # FEN: No IVF, replete electrolytes prn, speech and swallow evaluation;
   nectar thick liquids
   # Prophylaxis: Pneumoboots/Heparin, H2 blocker, bowel regimen
   # Access: PICC, Temporary HD line
   # Communication: Wife [**Telephone/Fax (1) 11266**]; [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 11365**] (daughter and nurse) [**Telephone/Fax (1) 11400**]; need to verify who is HCP
   # Code:  Full (discussed with patient and family)
   # Disposition: ICU pending clinical improvement
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Arterial Line - [**2128-1-27**] 12:30 PM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease, mechanical aortic valve replacement, atrial fibrillation, and a recent renal biopsy. He was admitted with MSSA bacteremia, torsades, and acute kidney injury (AKI) likely secondary to acute interstitial nephritis (AIN).

The patient's current status is as follows:

* Hemodynamics: Stable, with a blood pressure of 129/75 mmHg and a heart rate of 75 beats per minute.
* Respiratory status: Stable, with a SpO2 of 96% on nasal cannula oxygen.
* Renal status: Stable, with a creatinine level of 2.7 mg/dL and a blood urea nitrogen (BUN) level of 35.4 mg/dL.
* Infectious disease: The patient has a high-grade MSSA bacteremia, which is being treated with Vancomycin and Cefepime.
* Cardiovascular status: The patient has a mechanical aortic valve replacement and is being treated with anticoagulation therapy.
* Neurological status: The patient has a history of atrial fibrillation and is being treated with anticoagulation therapy.
* Gastrointestinal status: The patient has a history of hypertension and is being treated with antihypertensive medications.

Potential medical complications that may arise include:

* Flash pulmonary edema: The patient's history of pulmonary edema and diffuse alveolar hemorrhage increases the risk of flash pulmonary edema.
* Hemoptysis: The patient's history of hemoptysis and pulmonary edema increases the risk of hemoptysis.
* Vasculitis: The patient's history of vasculitis and AIN increases the risk of vasculitis.
* Endocarditis: The patient's history of MSSA bacteremia and mechanical aortic valve replacement increases the risk of endocarditis.
* Renal failure: The patient's history of AKI and AIN increases the risk of renal failure.
* Sepsis: The patient's history of MSSA bacteremia increases the risk of sepsis.
* Bleeding: The patient's history of bleeding and anticoagulation therapy increases the risk of bleeding.

The patient's plan of care includes:

* Continuing Vancomycin and Cefepime for MSSA bacteremia and endocarditis.
* Continuing anticoagulation therapy for atrial fibrillation and mechanical aortic valve replacement.
* Continuing treatment for AIN with high-dose steroids and monitoring for worsening renal function.
* Monitoring for signs of flash pulmonary edema and hemoptysis.
* Continuing to follow up with Renal, Rheumatology, Dermatology, and Infectious Disease services for further management and guidance.

Overall, the patient's complex medical history and current status require close monitoring and management to prevent potential complications and ensure optimal outcomes."
182149.0,283460,2128-02-03 11:28:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Respiratory Failure, renal failure
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Feels well this Am, no complaints
   24 Hour Events:
   Chest pain with HD yesterday - resolved spontaneously
   History obtained from [**Hospital 85**] Medical records, icu team
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Heparin Sodium - 1,100 units/hour
   Other ICU medications:
   Other medications:
   per icu resident note
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Genitourinary: Dialysis
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2128-2-3**] 11:28 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 80) bpm
   BP: 114/64(76) {105/51(61) - 130/85(96)} mmHg
   RR: 21 (15 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
   CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    915 mL
                                                                    233 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    675 mL
                                                                    233 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    205 mL
   Urine:
                                                                    300 mL
                                                                    205 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    615 mL
                                                                     28 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 99%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General Appearance: No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), mechanical S2
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right lower extremity edema: Trace, Left lower extremity
   edema: Trace
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed, pleasant,
   conversive
   Labs / Radiology
   11.6 g/dL
   290 K/uL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   1. Respiratory Failure: Extubated and doing well.  Cont cefepime
   2. Renal failure: HD per renal.  Cont steroid taper.
   3. DAH: Steroids as above --> CXR improving
   4. Complete Heart Block/Afib: Cont heparin gtt. Temp wire in place.
   5. MSSA bacteremia: Cont vanco
   Reaminder of issues per ICU team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: Heparin gtt)
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory Failure, renal failure
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   Feels well this Am, no complaints
   24 Hour Events:
   Chest pain with HD yesterday - resolved spontaneously
   History obtained from [**Hospital 85**] Medical records, icu team
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Cefipime - [**2128-2-1**] 12:00 PM
   Vancomycin - [**2128-2-2**] 01:00 PM
   Infusions:
   Heparin Sodium - 1,100 units/hour
   Other ICU medications:
   Other medications:
   per icu resident note
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fever
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Genitourinary: Dialysis
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2128-2-3**] 11:28 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**30**] AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.9
C (98.5
   HR: 75 (75 - 80) bpm
   BP: 114/64(76) {105/51(61) - 130/85(96)} mmHg
   RR: 21 (15 - 27) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Wgt (current): 69.1 kg (admission): 85 kg
   Height: 68 Inch
   CVP: 5 (-7 - 9)mmHg
   Total In:
                                                                    915 mL
                                                                    233 mL
   PO:
                                                                    240 mL
   TF:
   IVF:
                                                                    675 mL
                                                                    233 mL
   Blood products:
   Total out:
                                                                    300 mL
                                                                    205 mL
   Urine:
                                                                    300 mL
                                                                    205 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    615 mL
                                                                     28 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 99%
   ABG: 7.47/32/76.[**Numeric Identifier 128**]/21/0
   Physical Examination
   General Appearance: No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), mechanical S2
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender
   Extremities: Right lower extremity edema: Trace, Left lower extremity
   edema: Trace
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed, pleasant,
   conversive
   Labs / Radiology
   11.6 g/dL
   290 K/uL
   109 mg/dL
   3.0 mg/dL
   21 mEq/L
   4.0 mEq/L
   82 mg/dL
   103 mEq/L
   138 mEq/L
   35.4 %
   20.6 K/uL
        [image002.jpg]
                             [**2128-2-2**]  12:05 AM
                             [**2128-2-2**]  05:42 AM
                             [**2128-2-2**]  06:08 AM
                             [**2128-2-2**]  12:43 PM
                             [**2128-2-2**]  03:13 PM
                             [**2128-2-2**]  05:59 PM
                             [**2128-2-2**]  10:50 PM
                             [**2128-2-3**]  12:43 AM
                             [**2128-2-3**]  04:10 AM
                             [**2128-2-3**]  04:34 AM
   WBC
   22.4
   22.8
   20.6
   Hct
   40.8
   42.3
   38.1
   35.4
   Plt
   363
   304
   290
   Cr
   2.7
   3.2
   1.4
   2.5
   3.0
   TropT
   <0.01
   <0.01
   TCO2
   16
   23
   23
   23
   24
   Glucose
   132
   152
   188
   205
   109
   Other labs: PT / PTT / INR:15.4/65.0/1.4, CK / CKMB /
   Troponin-T:17//<0.01, ALT / AST:[**2-4**], Alk Phos / T Bili:104/1.7,
   Differential-Neuts:92.6 %, Lymph:3.5 %, Mono:2.5 %, Eos:1.2 %,
   Fibrinogen:407 mg/dL, Lactic Acid:1.3 mmol/L, LDH:333 IU/L, Ca++:9.0
   mg/dL, Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 HYPERGLYCEMIA
 ANEMIA, OTHER
 BACTEREMIA
 HEMOPTYSIS
 PNEUMONIA, [**Hospital 57**] HOSPITAL ACQUIRED (NON-VAP)
 ENDOCARDITIS, BACTERIAL
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name **])
 HYPOXEMIA
 HYPOTENSION (NOT SHOCK)
   76M with CAD s/p CABG, s/p mechanical AVR, Afib; admitted with MSSA
   bacteremia c/b CHB (s/p temp wire) as well as torsades; complicated
   with ARF likely secondary to AIN currently managed with CVVH and likely
   HD starting today, multifactorial DAH currently stable off extubation,
   leukocytoclastic vasculitis on legs currently improving.
   1. Respiratory Failure: Extubated and doing well.  Cont cefepime
   2. Renal failure: HD per renal.  Cont steroid taper.
   3. DAH: Steroids as above --> CXR improving
   4. Complete Heart Block/Afib: Cont heparin gtt. Temp wire in place.
   5. MSSA bacteremia: Cont vanco
   Reaminder of issues per ICU team.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   PICC Line - [**2128-1-27**] 08:05 AM
   Dialysis Catheter - [**2128-1-27**] 01:05 PM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: Heparin gtt)
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 76-year-old male with a complex medical history, including coronary artery disease (CAD) with a history of coronary artery bypass grafting (CABG) and mechanical aortic valve replacement (AVR). He is currently admitted to the intensive care unit (ICU) with multiple comorbidities, including:

1. Respiratory failure: The patient has been extubated and is doing well, but there is a risk of reintubation due to his underlying respiratory disease.
2. Renal failure: The patient has acute renal failure (ARF) likely secondary to acute interstitial nephritis (AIN), which is being managed with continuous veno-venous hemofiltration (CVVH) and hemodialysis (HD).
3. Dialysis-associated hemorrhage (DAH): The patient has multifactorial DAH, which is currently stable and managed with steroids.
4. Leukocytoclastic vasculitis: The patient has leukocytoclastic vasculitis on his legs, which is improving with treatment.
5. Complete heart block and atrial fibrillation (AFIB): The patient has a temporary wire in place, and heparin is being continued to manage his risk of bleeding.
6. MSSA bacteremia: The patient has methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia, which is being managed with vancomycin.
7. Hypertension: The patient has hypertension, which is being managed with antihypertensive medications.
8. Hyperglycemia: The patient has hyperglycemia, which is being managed with insulin therapy.
9. Hypoxemia: The patient has hypoxemia, which is being managed with oxygen therapy.
10. Hypotension: The patient has hypotension, which is being managed with vasopressors.

Potential medical complications that can arise from these comorbidities include:

1. Respiratory failure: Reintubation, pneumonia, and respiratory arrest.
2. Renal failure: Progression to chronic kidney disease, electrolyte imbalances, and acidosis.
3. Dialysis-associated hemorrhage: Bleeding complications, anemia, and hypovolemia.
4. Leukocytoclastic vasculitis: Worsening of vasculitis, skin necrosis, and organ damage.
5. Complete heart block and AFIB: Cardiac arrhythmias, cardiac arrest, and heart failure.
6. MSSA bacteremia: Sepsis, septic shock, and endocarditis.
7. Hypertension: Hypertensive crisis, cardiac damage, and stroke.
8. Hyperglycemia: Diabetic ketoacidosis, hyperosmolar non-ketotic syndrome, and diabetic coma.
9. Hypoxemia: Respiratory failure, cardiac arrest, and multi-organ failure.
10. Hypotension: Shock, organ failure, and cardiac arrest.

In conclusion, the patient has a complex medical condition with multiple comorbidities, and close monitoring and management are necessary to prevent potential complications."
